HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
110:@0.078769:0.033217:0.109813:0.033217:0.109813:0.013052:0.078769:0.013052:0.010348:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
to the cholinesterase inhibitors is heterogeneous,  so :@0.076190:0.084931:0.485145:0.084931:0.485145:0.069149:0.076190:0.069149:0.005125:0.009903:0.009268:0.005125:0.009223:0.009827:0.009268:0.009782:0.009223:0.009903:0.003024:0.003024:0.009223:0.009827:0.005866:0.005125:0.009827:0.004551:0.010326:0.005866:0.009827:0.009268:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.009268:0.003024:0.005866:0.009268:0.009223:0.009827:0.005125:0.009827:0.004551:0.009903:0.010175:0.009827:0.009223:0.009827:0.009903:0.009192:0.005866:0.004188:0.004188:0.005050:0.005866:0.009903:0.004188
some patients do markedly better than others. Further-:@0.076190:0.098913:0.480957:0.098913:0.480957:0.083130:0.076190:0.083130:0.005866:0.009903:0.014182:0.009827:0.005110:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005110:0.010357:0.009903:0.005110:0.014182:0.010326:0.004551:0.007590:0.009827:0.010357:0.003024:0.008104:0.005110:0.010311:0.009827:0.005125:0.005125:0.009827:0.004551:0.005110:0.005125:0.009223:0.010326:0.009223:0.005110:0.009903:0.005125:0.009223:0.009827:0.004551:0.005866:0.004188:0.005110:0.007333:0.009192:0.004551:0.005125:0.009223:0.009827:0.004551:0.005020
more, these agents do not cure the disease, but rather :@0.076190:0.112894:0.485160:0.112894:0.485160:0.097112:0.076190:0.097112:0.014182:0.009903:0.004551:0.009827:0.004188:0.004672:0.005125:0.009223:0.009827:0.005866:0.009827:0.004687:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.004687:0.010357:0.009903:0.004687:0.009223:0.009903:0.005125:0.004687:0.009782:0.009192:0.004551:0.009827:0.004687:0.005125:0.009223:0.009827:0.004687:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.004687:0.010311:0.009192:0.005125:0.004687:0.004551:0.010326:0.005125:0.009223:0.009827:0.004551:0.004188
slow its progression. While there may be some benefit to :@0.076190:0.126876:0.485115:0.126876:0.485115:0.111093:0.076190:0.111093:0.005866:0.003024:0.009903:0.012564:0.003855:0.003024:0.005125:0.005866:0.003855:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005851:0.005866:0.003024:0.009903:0.009223:0.004188:0.003840:0.014514:0.009223:0.003024:0.003024:0.009827:0.003840:0.005125:0.009223:0.009827:0.004536:0.009827:0.003840:0.014182:0.010326:0.008104:0.003855:0.010311:0.009827:0.003840:0.005866:0.009903:0.014182:0.009827:0.003840:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.003840:0.005125:0.009903:0.004188
continuing therapy in patients with advanced disease, :@0.076190:0.140857:0.485145:0.140857:0.485145:0.125075:0.076190:0.125075:0.009782:0.009903:0.009223:0.005125:0.003024:0.009223:0.009192:0.003024:0.009223:0.010175:0.005080:0.005125:0.009223:0.009827:0.004536:0.010326:0.010311:0.008104:0.005095:0.003024:0.009223:0.005095:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005095:0.012564:0.003024:0.005125:0.009223:0.005095:0.010326:0.010357:0.008376:0.010326:0.009223:0.009782:0.009827:0.010357:0.005095:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.004188
it has been suggested that cholinesterase medication :@0.076190:0.154839:0.485160:0.154839:0.485160:0.139056:0.076190:0.139056:0.003024:0.005125:0.005942:0.009223:0.010326:0.005866:0.005942:0.010311:0.009827:0.009827:0.009223:0.005942:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.009827:0.010357:0.005942:0.005125:0.009223:0.010326:0.005125:0.005942:0.009782:0.009223:0.009903:0.003024:0.003024:0.009223:0.009827:0.005866:0.005125:0.009827:0.004551:0.010326:0.005866:0.009827:0.005942:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
be withdrawn once the MMsE falls to less than 12.  sub-:@0.076190:0.168820:0.480947:0.168845:0.480947:0.153062:0.076190:0.153038:0.010311:0.009827:0.003810:0.012564:0.003024:0.005125:0.009223:0.010357:0.004551:0.010326:0.012564:0.009223:0.003810:0.009903:0.009223:0.009782:0.009827:0.003810:0.005125:0.009223:0.009827:0.003810:0.013894:0.013894:0.007529:0.008104:0.003810:0.004747:0.010326:0.003024:0.003024:0.005866:0.003825:0.005125:0.009903:0.003810:0.003024:0.009827:0.005866:0.005866:0.003825:0.005125:0.009223:0.010326:0.009223:0.003810:0.008376:0.008376:0.004188:0.009712:0.003810:0.007529:0.009192:0.010311:0.633157
50:@0.435366:0.163546:0.445082:0.163546:0.445082:0.154392:0.435366:0.154392:0.004858:0.004858
sequent rapid deterioration following withdrawal occa-:@0.076196:0.182827:0.480947:0.182827:0.480947:0.167044:0.076196:0.167044:0.005866:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.004112:0.004551:0.010326:0.010311:0.003024:0.010357:0.004112:0.010357:0.009827:0.005125:0.009827:0.004551:0.003024:0.009903:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004097:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.003024:0.009223:0.010175:0.004112:0.012564:0.003024:0.005125:0.009223:0.010357:0.004551:0.010326:0.012564:0.010326:0.003024:0.004127:0.009903:0.009782:0.009782:0.010326:0.005020
sionally occurs, and would suggest that there was still :@0.076196:0.196808:0.485135:0.196808:0.485135:0.181025:0.076196:0.181025:0.005866:0.003024:0.009903:0.009223:0.010326:0.003024:0.003024:0.008104:0.006335:0.009903:0.009782:0.009782:0.009192:0.004551:0.005866:0.004188:0.006320:0.010326:0.009223:0.010357:0.006335:0.012564:0.009903:0.009192:0.003024:0.010357:0.006335:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.006335:0.005125:0.009223:0.010326:0.005125:0.006335:0.005125:0.009223:0.009827:0.004551:0.009827:0.006320:0.012564:0.010326:0.005866:0.006335:0.005866:0.005125:0.003024:0.003024:0.003024:0.004188
some value in the therapy.  In these cases, it would be :@0.076196:0.210790:0.485138:0.210802:0.485138:0.195019:0.076196:0.195007:0.005866:0.009903:0.014182:0.009827:0.004475:0.008376:0.010326:0.003024:0.009192:0.009827:0.004475:0.003024:0.009223:0.004475:0.005125:0.009223:0.009827:0.004475:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.009709:0.004475:0.003417:0.009223:0.004475:0.005125:0.009223:0.009827:0.005866:0.009827:0.004475:0.009782:0.010326:0.005866:0.009827:0.005866:0.004188:0.004475:0.003024:0.005125:0.004475:0.012564:0.009903:0.009192:0.003024:0.010357:0.004475:0.010311:0.009827:0.573192
51:@0.272687:0.205503:0.282403:0.205503:0.282403:0.196349:0.272687:0.196349:0.004858:0.004858
reasonable to restart therapy and monitor closely for im-:@0.076183:0.224783:0.480919:0.224783:0.480919:0.209001:0.076183:0.209001:0.004551:0.009827:0.010326:0.005866:0.009903:0.009223:0.010326:0.010311:0.003024:0.009827:0.003372:0.005125:0.009903:0.003356:0.004551:0.009827:0.005866:0.005125:0.010326:0.004551:0.005125:0.003356:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.003372:0.010326:0.009223:0.010357:0.003372:0.014182:0.009903:0.009223:0.003024:0.005125:0.009903:0.004551:0.003356:0.009782:0.003024:0.009903:0.005866:0.009827:0.003024:0.008104:0.003372:0.004747:0.009903:0.004551:0.003356:0.003024:0.014182:0.005020
provement. This must be done as soon as possible and :@0.076183:0.238765:0.485123:0.238765:0.485123:0.222982:0.076183:0.222982:0.010311:0.004551:0.009903:0.008376:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188:0.005050:0.006441:0.009223:0.003024:0.005866:0.005065:0.014182:0.009192:0.005866:0.005125:0.005065:0.010311:0.009827:0.005065:0.010357:0.009903:0.009223:0.009827:0.005065:0.010326:0.005866:0.005065:0.005866:0.009903:0.009903:0.009223:0.005050:0.010326:0.005866:0.005065:0.010311:0.009903:0.005866:0.005866:0.003024:0.010311:0.003024:0.009827:0.005065:0.010326:0.009223:0.010357:0.004188
preferably within 7-10 days.:@0.076183:0.252746:0.275497:0.252746:0.275497:0.236964:0.076183:0.236964:0.010311:0.004551:0.009827:0.004747:0.009827:0.004551:0.010326:0.010311:0.003024:0.008104:0.004188:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.004188:0.008376:0.005020:0.008376:0.008376:0.004188:0.010357:0.010326:0.008104:0.005866:0.004188
steP 7: reAssessment:@0.076190:0.285491:0.269109:0.285491:0.269109:0.265327:0.076190:0.265327:0.009609:0.007761:0.009609:0.010348:0.005174:0.010348:0.005174:0.005174:0.010718:0.009609:0.013674:0.009609:0.009609:0.009609:0.009609:0.009609:0.016631:0.009609:0.013674:0.007761
should there be no response to a clinical trial of optimal :@0.076190:0.301255:0.485130:0.301255:0.485130:0.285472:0.076190:0.285472:0.007529:0.009223:0.009903:0.009192:0.003024:0.010357:0.003916:0.005125:0.009223:0.009827:0.004551:0.009827:0.003916:0.010311:0.009827:0.003916:0.009223:0.009903:0.003916:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.003916:0.005125:0.009903:0.003916:0.010326:0.003916:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.003931:0.005125:0.004551:0.003024:0.010326:0.003024:0.003916:0.009903:0.004747:0.003916:0.009903:0.010311:0.005125:0.003024:0.014182:0.010326:0.003024:0.004188
dose and duration, it may be useful to reassess a num-:@0.076190:0.315237:0.480942:0.315237:0.480942:0.299454:0.076190:0.299454:0.010357:0.009903:0.005866:0.009827:0.004929:0.010326:0.009223:0.010357:0.004929:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004929:0.003024:0.005125:0.004929:0.014182:0.010326:0.008104:0.004929:0.010311:0.009827:0.004929:0.009192:0.005866:0.009827:0.004747:0.009192:0.003024:0.004929:0.005125:0.009903:0.004929:0.004551:0.009827:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.004929:0.010326:0.004929:0.009223:0.009192:0.014182:0.005020
ber of factors. The diagnosis of AD should be reconsid-:@0.076190:0.329218:0.480942:0.329218:0.480942:0.313435:0.076190:0.313435:0.010311:0.009827:0.004551:0.005035:0.009903:0.004747:0.005035:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188:0.005035:0.006441:0.009223:0.009827:0.005035:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.005050:0.009903:0.004747:0.005035:0.011188:0.011249:0.005035:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005035:0.010311:0.009827:0.005035:0.004551:0.009827:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.005020
ered; in particular, other types of dementia should be :@0.076190:0.343200:0.485145:0.343200:0.485145:0.327417:0.076190:0.327417:0.009827:0.004551:0.009827:0.010357:0.004188:0.005896:0.003024:0.009223:0.005912:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.005912:0.009903:0.005125:0.009223:0.009827:0.004551:0.005896:0.005125:0.008104:0.010311:0.009827:0.005866:0.005912:0.009903:0.004747:0.005912:0.010357:0.009827:0.014182:0.009827:0.009223:0.005125:0.003024:0.010326:0.005912:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005912:0.010311:0.009827:0.004188
excluded (although there is evidence that cholinester-:@0.076190:0.357181:0.480957:0.357181:0.480957:0.341399:0.076190:0.341399:0.009827:0.007257:0.009782:0.003024:0.009192:0.010357:0.009827:0.010357:0.005246:0.005579:0.010326:0.003024:0.005125:0.009223:0.009903:0.009192:0.010175:0.009223:0.005246:0.005125:0.009223:0.009827:0.004551:0.009827:0.005246:0.003024:0.005866:0.005261:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.005246:0.005125:0.009223:0.010326:0.005125:0.005246:0.009782:0.009223:0.009903:0.003024:0.003024:0.009223:0.009827:0.005866:0.005125:0.009827:0.004551:0.005020
ase inhibitors may be useful in treating dementia due to :@0.076190:0.371163:0.485145:0.371163:0.485145:0.355380:0.076190:0.355380:0.010326:0.005866:0.009827:0.003886:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.003886:0.014182:0.010326:0.008104:0.003886:0.010311:0.009827:0.003886:0.009192:0.005866:0.009827:0.004747:0.009192:0.003024:0.003886:0.003024:0.009223:0.003886:0.005125:0.004551:0.009827:0.010326:0.005125:0.003024:0.009223:0.010175:0.003870:0.010357:0.009827:0.014182:0.009827:0.009223:0.005125:0.003024:0.010326:0.003886:0.010357:0.009192:0.009827:0.003886:0.005125:0.009903:0.004188
other causes, such as Lewy body dementia or parkin-:@0.076190:0.385144:0.480957:0.385144:0.480957:0.369362:0.076190:0.369362:0.009903:0.005125:0.009223:0.009827:0.004551:0.006199:0.009782:0.010326:0.009192:0.005866:0.009827:0.005866:0.004188:0.006214:0.005866:0.009192:0.009782:0.009223:0.006199:0.010326:0.005866:0.006214:0.006985:0.009827:0.012564:0.008104:0.006214:0.010311:0.009903:0.010357:0.008104:0.006199:0.010357:0.009827:0.014182:0.009827:0.009223:0.005125:0.003024:0.010326:0.006199:0.009903:0.004551:0.006214:0.008950:0.010326:0.004551:0.007590:0.003024:0.009223:0.005020
son’s disease dementia).  :@0.076190:0.399126:0.271394:0.399154:0.271394:0.383372:0.076190:0.383343:0.005866:0.009903:0.009223:0.005307:0.005866:0.004188:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004188:0.010357:0.009827:0.014182:0.009827:0.009223:0.005125:0.003024:0.010326:0.005579:0.004188:0.009723:0.540284
52:@0.257486:0.393856:0.267202:0.393856:0.267202:0.384702:0.257486:0.384702:0.004858:0.004858
It is also important to reconsider the diagnosis of de-:@0.090479:0.413136:0.480974:0.413136:0.480974:0.397353:0.090479:0.397353:0.003115:0.004823:0.006894:0.002721:0.005564:0.006894:0.010024:0.002721:0.005564:0.009601:0.006894:0.002721:0.013879:0.010009:0.009601:0.004248:0.004823:0.010024:0.008920:0.004823:0.006894:0.004823:0.009601:0.006894:0.004248:0.009525:0.009480:0.009601:0.008920:0.005564:0.002721:0.010054:0.009525:0.004248:0.006894:0.004823:0.008920:0.009525:0.006894:0.010054:0.002721:0.010024:0.009873:0.008920:0.009601:0.005564:0.002721:0.005564:0.006894:0.009601:0.004445:0.006894:0.010054:0.009525:0.005020
pression. Not only may patients with AD have comorbid :@0.076192:0.427117:0.485116:0.427117:0.485116:0.411335:0.076192:0.411335:0.010009:0.004248:0.009525:0.005564:0.005564:0.002721:0.009601:0.008920:0.003886:0.005655:0.010886:0.009601:0.004823:0.005655:0.009601:0.008920:0.002721:0.007801:0.005655:0.013879:0.010024:0.007801:0.005655:0.010009:0.010024:0.004823:0.002721:0.009525:0.008920:0.004823:0.005564:0.005655:0.012262:0.002721:0.004823:0.008920:0.005655:0.010886:0.010946:0.005655:0.008920:0.010024:0.008074:0.009525:0.005655:0.009480:0.009601:0.013879:0.009601:0.004248:0.010009:0.002721:0.010357:0.004188
depression, but depression may result in the misdiagnosis :@0.076192:0.441099:0.485116:0.441099:0.485116:0.425316:0.076192:0.425316:0.010054:0.009525:0.010009:0.004248:0.009525:0.005564:0.005564:0.002721:0.009601:0.008920:0.003886:0.005110:0.010009:0.008890:0.004823:0.005110:0.010054:0.009525:0.010009:0.004248:0.009525:0.005564:0.005564:0.002721:0.009601:0.008920:0.005110:0.013879:0.010024:0.007801:0.005110:0.004248:0.009525:0.005564:0.008890:0.002721:0.004823:0.005110:0.002721:0.008920:0.005110:0.004823:0.008920:0.009525:0.005110:0.013879:0.002721:0.005564:0.010054:0.002721:0.010024:0.009873:0.008920:0.009601:0.005564:0.002721:0.005866:0.004188
of dementia (“pseudodementia”).  A trial of antidepres-:@0.076192:0.455080:0.480949:0.455097:0.480949:0.439314:0.076192:0.439298:0.009601:0.004445:0.005020:0.010054:0.009525:0.013879:0.009525:0.008920:0.004823:0.002721:0.010024:0.005020:0.005277:0.007287:0.010009:0.005564:0.009525:0.008890:0.010054:0.009601:0.010054:0.009525:0.013879:0.009525:0.008920:0.004823:0.002721:0.010024:0.007015:0.005277:0.004188:0.009061:0.005020:0.010886:0.005020:0.004823:0.004248:0.002721:0.010024:0.002721:0.005020:0.009601:0.004445:0.005020:0.010024:0.008920:0.004823:0.002721:0.010054:0.009525:0.010009:0.004248:0.009525:0.005564:0.258303
53:@0.321599:0.449798:0.331140:0.449798:0.331140:0.440644:0.321599:0.440644:0.004683:0.004858
sants may be the only way to exclude these possibilities.:@0.076197:0.469078:0.468082:0.469078:0.468082:0.453296:0.076197:0.453296:0.005564:0.010024:0.008920:0.004823:0.005564:0.003886:0.013879:0.010024:0.007801:0.003886:0.010009:0.009525:0.003886:0.004823:0.008920:0.009525:0.003886:0.009601:0.008920:0.002721:0.007801:0.003886:0.012262:0.010024:0.007801:0.003886:0.004823:0.009601:0.003886:0.009525:0.006955:0.009480:0.002721:0.008890:0.010054:0.009525:0.003886:0.004823:0.008920:0.009525:0.005564:0.009525:0.003886:0.010009:0.009601:0.005564:0.005564:0.002721:0.010009:0.002721:0.002721:0.002721:0.004823:0.002721:0.009525:0.005564:0.004188
steP 8: treAtment resistAnCe:@0.076190:0.499249:0.345612:0.499249:0.345612:0.479085:0.076190:0.479085:0.009609:0.007761:0.009609:0.010348:0.005174:0.010348:0.005174:0.005174:0.007761:0.010718:0.009609:0.013674:0.007761:0.016631:0.009609:0.013674:0.007761:0.005174:0.010718:0.009609:0.009609:0.005174:0.009609:0.007761:0.013674:0.013674:0.014413:0.009609
There is evidence that if a patient does not respond to :@0.076190:0.515013:0.485145:0.515013:0.485145:0.499230:0.076190:0.499230:0.006441:0.009223:0.009827:0.004551:0.009827:0.004959:0.003024:0.005866:0.004974:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.004959:0.005125:0.009223:0.010326:0.005125:0.004959:0.003024:0.004747:0.004974:0.010326:0.004974:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004959:0.010357:0.009903:0.009827:0.005866:0.004959:0.009223:0.009903:0.005125:0.004959:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.010357:0.004959:0.005125:0.009903:0.004188
one cholinesterase inhibitor, switching to another may :@0.076190:0.528995:0.485145:0.528995:0.485145:0.513212:0.076190:0.513212:0.009903:0.009223:0.009827:0.005836:0.009782:0.009223:0.009903:0.003024:0.003024:0.009223:0.009827:0.005866:0.005125:0.009827:0.004551:0.010326:0.005866:0.009827:0.005836:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.004188:0.005836:0.005866:0.012564:0.003024:0.005125:0.009782:0.009223:0.003024:0.009223:0.010175:0.005836:0.005125:0.009903:0.005836:0.010326:0.009223:0.009903:0.005125:0.009223:0.009827:0.004551:0.005821:0.014182:0.010326:0.008104:0.004188
be useful.  A switch to memantine should also be con-:@0.076190:0.542976:0.480942:0.542984:0.480942:0.527202:0.076190:0.527194:0.010311:0.009827:0.004596:0.009192:0.005866:0.009827:0.004747:0.009192:0.003024:0.004188:0.009722:0.004596:0.011188:0.004596:0.005866:0.012564:0.003024:0.005125:0.009782:0.009223:0.004596:0.005125:0.009903:0.004596:0.014182:0.009827:0.014182:0.010326:0.009223:0.005125:0.003024:0.009223:0.009827:0.004596:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004596:0.010326:0.003024:0.005866:0.009903:0.004596:0.010311:0.009827:0.004596:0.009782:0.009903:0.009223:0.143218
54:@0.146965:0.537685:0.156681:0.537685:0.156681:0.528532:0.146965:0.528532:0.004858:0.004858
sidered, especially in moderate to severe AD.  :@0.076191:0.556966:0.422591:0.556970:0.422591:0.541187:0.076191:0.541183:0.005866:0.003024:0.010357:0.009827:0.004551:0.009827:0.010357:0.004188:0.004188:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.004188:0.003024:0.009223:0.004188:0.014182:0.009903:0.010357:0.009827:0.004551:0.010326:0.005125:0.009827:0.004188:0.005125:0.009903:0.004188:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.004188:0.011188:0.011249:0.004188:0.009700:0.182423
55:@0.408684:0.551671:0.418400:0.551671:0.418400:0.542517:0.408684:0.542517:0.004858:0.004858
While development of several new pharmacothera-:@0.090471:0.570951:0.480951:0.570951:0.480951:0.555169:0.090471:0.555169:0.014514:0.009223:0.003024:0.003024:0.009827:0.006032:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.014182:0.009827:0.009223:0.005125:0.006032:0.009903:0.004747:0.006032:0.005866:0.009827:0.008376:0.009827:0.004551:0.010326:0.003024:0.006032:0.009223:0.009827:0.012564:0.006032:0.010311:0.009223:0.010326:0.004551:0.014182:0.010326:0.009782:0.009903:0.005125:0.009223:0.009827:0.004551:0.010311:0.005020
peutic  interventions  for  AD  is currently  underway:@0.076184:0.584933:0.454901:0.584933:0.454901:0.569150:0.076184:0.569150:0.010311:0.009827:0.009192:0.005125:0.003024:0.009782:0.004188:0.004324:0.003024:0.009223:0.005125:0.009827:0.004551:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.004324:0.004747:0.009903:0.004551:0.004188:0.004324:0.011188:0.011249:0.004188:0.004324:0.003024:0.005866:0.008527:0.009782:0.009192:0.004551:0.004551:0.009827:0.009223:0.005125:0.003024:0.008104:0.004188:0.004324:0.009192:0.009223:0.010357:0.009827:0.004551:0.012564:0.010326:0.008104
56,57:@0.454899:0.579642:0.476761:0.579642:0.476761:0.570488:0.454899:0.570488:0.004858:0.004858:0.002429:0.004858:0.004858
, :@0.476766:0.584941:0.485142:0.584941:0.485142:0.569159:0.476766:0.569159:0.004188:0.004188
symptomatic management  and  caring  for  the  care-:@0.076188:0.598923:0.480954:0.598923:0.480954:0.583140:0.076188:0.583140:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.010326:0.005125:0.003024:0.009782:0.007771:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188:0.003568:0.010326:0.009223:0.010357:0.004188:0.003568:0.009782:0.010326:0.004551:0.003024:0.009223:0.010175:0.004188:0.003568:0.004747:0.009903:0.004551:0.004188:0.003568:0.005125:0.009223:0.009827:0.004188:0.003568:0.009782:0.010326:0.004551:0.009827:0.005020
giver may remain the main forms of intervention  for :@0.076188:0.612904:0.485127:0.612904:0.485127:0.597122:0.076188:0.597122:0.010175:0.003024:0.008376:0.009827:0.004551:0.008074:0.014182:0.010326:0.008104:0.008074:0.004551:0.009827:0.014182:0.010326:0.003024:0.009223:0.008074:0.005125:0.009223:0.009827:0.008074:0.014182:0.010326:0.003024:0.009223:0.008074:0.004747:0.009903:0.004551:0.014182:0.005866:0.008074:0.009903:0.004747:0.008074:0.003024:0.009223:0.005125:0.009827:0.004551:0.008376:0.009827:0.009223:0.005125:0.003024:0.009903:0.009223:0.004188:0.003870:0.004747:0.009903:0.004551:0.004188
some time. Measures to address caregiver burden, such :@0.076188:0.626886:0.485142:0.626886:0.485142:0.611103:0.076188:0.611103:0.005866:0.009903:0.014182:0.009827:0.003568:0.005125:0.003024:0.014182:0.009827:0.004188:0.003568:0.013894:0.009827:0.010326:0.005866:0.009192:0.004551:0.009827:0.005866:0.003568:0.005125:0.009903:0.003568:0.010326:0.010357:0.010357:0.004551:0.009827:0.005866:0.005866:0.003568:0.009782:0.010326:0.004551:0.009827:0.010175:0.003024:0.008376:0.009827:0.004551:0.003568:0.010311:0.009192:0.004551:0.010357:0.009827:0.009223:0.004188:0.003553:0.005866:0.009192:0.009782:0.009223:0.004188
as referral of the caregiver to an AD consumer advo-:@0.076188:0.640867:0.480969:0.640867:0.480969:0.625085:0.076188:0.625085:0.010326:0.005866:0.006048:0.004551:0.009827:0.004747:0.009827:0.004551:0.004551:0.010326:0.003024:0.006048:0.009903:0.004747:0.006048:0.005125:0.009223:0.009827:0.006048:0.009782:0.010326:0.004551:0.009827:0.010175:0.003024:0.008376:0.009827:0.004551:0.006032:0.005125:0.009903:0.006048:0.010326:0.009223:0.006048:0.011188:0.011249:0.006048:0.009782:0.009903:0.009223:0.005866:0.009192:0.014182:0.009827:0.004551:0.006032:0.010326:0.010357:0.008376:0.009903:0.005020
cacy group, may be useful.  :@0.076188:0.654849:0.291939:0.654869:0.291939:0.639086:0.076188:0.639066:0.009782:0.010326:0.009782:0.008104:0.004188:0.010175:0.004551:0.009903:0.009192:0.010311:0.004188:0.004188:0.014182:0.010326:0.008104:0.004188:0.010311:0.009827:0.004188:0.009192:0.005866:0.009827:0.004747:0.009192:0.003024:0.004188:0.009709:0.184874
58:@0.278031:0.649570:0.287747:0.649570:0.287747:0.640417:0.278031:0.640417:0.004858:0.004858
ADDitiOnAl reADinG:@0.076191:0.687602:0.271327:0.687602:0.271327:0.667437:0.076191:0.667437:0.013674:0.012935:0.012935:0.005174:0.007761:0.005174:0.015522:0.013674:0.013674:0.008131:0.005174:0.010718:0.009609:0.013674:0.012935:0.005174:0.013674:0.015522
1.  National  Institute  for  Health  and  Clinical Excellence.  De-:@0.076191:0.701176:0.480937:0.701176:0.480937:0.687147:0.076191:0.687147:0.007445:0.003723:0.003723:0.008628:0.009945:0.009179:0.004556:0.002688:0.008803:0.008198:0.009179:0.002688:0.003723:0.002648:0.003037:0.008198:0.005214:0.004556:0.002688:0.004556:0.008171:0.004556:0.008735:0.003723:0.002648:0.004220:0.008803:0.004045:0.003723:0.002648:0.009179:0.008735:0.009179:0.002688:0.004556:0.008198:0.003723:0.002648:0.009179:0.008198:0.009206:0.003723:0.002648:0.010926:0.002688:0.002688:0.008198:0.002688:0.008695:0.009179:0.002688:0.006384:0.007203:0.006451:0.008695:0.008735:0.002688:0.002688:0.008735:0.008198:0.008695:0.008735:0.003723:0.003723:0.002648:0.009999:0.008735:0.004462
mentia: supporting people with dementia and their carers :@0.099709:0.713368:0.484673:0.713368:0.484673:0.699339:0.099709:0.699339:0.012606:0.008735:0.008198:0.004556:0.002688:0.009179:0.003723:0.004072:0.006693:0.008171:0.009165:0.009165:0.008803:0.004045:0.004556:0.002688:0.008198:0.009045:0.004072:0.009165:0.008735:0.008803:0.009165:0.002688:0.008735:0.004072:0.011168:0.002688:0.004556:0.008198:0.004072:0.009206:0.008735:0.012606:0.008735:0.008198:0.004556:0.002688:0.009179:0.004072:0.009179:0.008198:0.009206:0.004072:0.004556:0.008198:0.008735:0.002688:0.004045:0.004072:0.008695:0.009179:0.004045:0.008735:0.004045:0.005214:0.003723
in health and social care: National Institute for Health and :@0.099709:0.725560:0.484660:0.725560:0.484660:0.711531:0.099709:0.711531:0.002688:0.008198:0.004381:0.008198:0.008735:0.009179:0.002688:0.004556:0.008198:0.004381:0.009179:0.008198:0.009206:0.004381:0.005214:0.008803:0.008695:0.002688:0.009179:0.002688:0.004395:0.008695:0.009179:0.004045:0.008735:0.003723:0.004381:0.009945:0.009179:0.004556:0.002688:0.008803:0.008184:0.009179:0.002688:0.004381:0.003037:0.008198:0.005214:0.004556:0.002688:0.004556:0.008171:0.004556:0.008735:0.004381:0.004220:0.008803:0.004045:0.004381:0.009179:0.008735:0.009179:0.002688:0.004556:0.008198:0.004381:0.009179:0.008198:0.009206:0.003723
Care Excellence; 2006 [cited 2014]. Available from: https://:@0.099709:0.737752:0.480964:0.737752:0.480964:0.723723:0.099709:0.723723:0.010926:0.009179:0.004045:0.008735:0.003561:0.007203:0.006451:0.008695:0.008735:0.002688:0.002688:0.008735:0.008198:0.008695:0.008735:0.003723:0.003561:0.007445:0.007445:0.007445:0.007445:0.003575:0.004717:0.008695:0.002688:0.004556:0.008735:0.009206:0.003561:0.007445:0.007445:0.007445:0.007459:0.004717:0.003723:0.003561:0.009945:0.007445:0.009179:0.002688:0.002688:0.009179:0.009165:0.002688:0.008735:0.003575:0.004220:0.004045:0.008803:0.012606:0.003723:0.003548:0.008198:0.004556:0.004556:0.009165:0.005214:0.003723:0.005873:0.005873
www.nice.org.uk/guidance/cg42.:@0.099709:0.749944:0.321522:0.749944:0.321522:0.735915:0.099709:0.735915:0.011168:0.011168:0.011168:0.003723:0.008198:0.002688:0.008695:0.008735:0.003723:0.008803:0.004045:0.009045:0.003723:0.008171:0.006746:0.005873:0.009045:0.008171:0.002688:0.009206:0.009179:0.008198:0.008695:0.008735:0.005873:0.008695:0.009045:0.007445:0.007445:0.003723
2.  Rabins pV, Blacker D, Rovner BW, Rummans T, schneider Ls, :@0.076191:0.762136:0.484673:0.762136:0.484673:0.748107:0.076191:0.748107:0.007445:0.003723:0.003723:0.008628:0.008158:0.009179:0.009165:0.002688:0.008198:0.005214:0.003440:0.007956:0.009434:0.003723:0.003427:0.007714:0.002688:0.009179:0.008695:0.006746:0.008735:0.004045:0.003440:0.009999:0.003723:0.003427:0.008158:0.008803:0.007445:0.008198:0.008735:0.004045:0.003427:0.007714:0.012902:0.003723:0.003440:0.008158:0.008171:0.012606:0.012606:0.009179:0.008198:0.005214:0.003427:0.005725:0.003723:0.003427:0.006693:0.008695:0.008198:0.008198:0.008735:0.002688:0.009206:0.008735:0.004045:0.003427:0.006209:0.006693:0.003723:0.003723
Tariot pN, :@0.099709:0.774328:0.164714:0.774328:0.164714:0.760299:0.099709:0.760299:0.005725:0.009179:0.004045:0.002688:0.008803:0.004556:0.004677:0.007956:0.009932:0.003723:0.003723
et al:@0.165682:0.774328:0.195530:0.774328:0.195530:0.760299:0.165682:0.760299:0.008735:0.004556:0.004690:0.009179:0.002688
. American psychiatric Association practice :@0.195530:0.774328:0.484687:0.774328:0.484687:0.760299:0.195530:0.760299:0.003723:0.004690:0.009945:0.012606:0.008735:0.004045:0.002688:0.008695:0.009179:0.008198:0.004690:0.007956:0.005214:0.007203:0.008695:0.008198:0.002688:0.009179:0.004556:0.004045:0.002688:0.008695:0.004690:0.009945:0.005214:0.005214:0.008803:0.008695:0.002688:0.009179:0.004556:0.002688:0.008803:0.008198:0.004690:0.009165:0.004045:0.009179:0.008695:0.004556:0.002688:0.008695:0.008735:0.003723
guideline for the treatment of patients with Alzheimer’s dis-:@0.099709:0.786520:0.480937:0.786520:0.480937:0.772491:0.099709:0.772491:0.009045:0.008171:0.002688:0.009206:0.008735:0.002688:0.002688:0.008198:0.008735:0.003830:0.004220:0.008803:0.004045:0.003817:0.004556:0.008198:0.008735:0.003817:0.004556:0.004045:0.008735:0.009179:0.004556:0.012606:0.008735:0.008198:0.004556:0.003817:0.008803:0.004220:0.003817:0.009165:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.005214:0.003830:0.011168:0.002688:0.004556:0.008198:0.003830:0.009945:0.002688:0.005712:0.008198:0.008735:0.002688:0.012606:0.008735:0.004045:0.004717:0.005214:0.003817:0.009206:0.002688:0.005214:0.004462
ease and other dementias. second edition. :@0.099709:0.798712:0.389269:0.798712:0.389269:0.784683:0.099709:0.784683:0.008735:0.009179:0.005214:0.008735:0.004260:0.009179:0.008198:0.009206:0.004260:0.008803:0.004556:0.008198:0.008735:0.004045:0.004247:0.009206:0.008735:0.012606:0.008735:0.008198:0.004556:0.002688:0.009179:0.005214:0.003723:0.004260:0.006693:0.008735:0.008695:0.008803:0.008198:0.009206:0.004260:0.008735:0.009206:0.002688:0.004556:0.002688:0.008803:0.008198:0.003723:0.003723
Am J Psychia-:@0.389806:0.798712:0.480951:0.798712:0.480951:0.784683:0.389806:0.784683:0.009945:0.012606:0.004260:0.006478:0.004260:0.007956:0.005214:0.007203:0.008695:0.008198:0.002688:0.009179:0.004462
try.:@0.099709:0.810904:0.119236:0.810904:0.119236:0.796875:0.099709:0.796875:0.004556:0.004045:0.007203:0.003723
 2007;164(12 suppl):5-56.:@0.119236:0.810904:0.277455:0.810904:0.277455:0.796875:0.119236:0.796875:0.003723:0.007445:0.007445:0.007445:0.007445:0.003723:0.007445:0.007445:0.007445:0.004959:0.007445:0.007445:0.003723:0.006693:0.008171:0.009165:0.009165:0.002688:0.004959:0.003723:0.007445:0.004462:0.007445:0.007445:0.003723
3.  Muayqil T, Camicioli R. systematic review and meta-anal-:@0.076191:0.823096:0.480951:0.823096:0.480951:0.809067:0.076191:0.809067:0.007445:0.003723:0.003723:0.008628:0.012351:0.008171:0.009179:0.007203:0.009165:0.002688:0.002688:0.004972:0.005725:0.003723:0.004959:0.010926:0.009179:0.012606:0.002688:0.008695:0.002688:0.008803:0.002688:0.002688:0.004972:0.008158:0.003723:0.004959:0.006693:0.007203:0.005214:0.004556:0.008735:0.012606:0.009179:0.004556:0.002688:0.008695:0.004959:0.004045:0.008735:0.007445:0.002688:0.008735:0.011168:0.004959:0.009179:0.008198:0.009206:0.004959:0.012606:0.008735:0.004556:0.009179:0.004462:0.009179:0.008198:0.009179:0.002688:0.004462
ysis  of combination therapy with cholinesterase inhibitors :@0.099709:0.835288:0.484673:0.835288:0.484673:0.821259:0.099709:0.821259:0.007203:0.005214:0.002688:0.005214:0.003723:0.002406:0.008803:0.004220:0.006115:0.008695:0.008803:0.012606:0.009165:0.002688:0.008198:0.009179:0.004556:0.002688:0.008803:0.008198:0.006115:0.004556:0.008198:0.008735:0.004045:0.009179:0.009165:0.007203:0.006115:0.011168:0.002688:0.004556:0.008198:0.006115:0.008695:0.008198:0.008803:0.002688:0.002688:0.008198:0.008735:0.005214:0.004556:0.008735:0.004045:0.009179:0.005214:0.008735:0.006115:0.002688:0.008198:0.008198:0.002688:0.009165:0.002688:0.004556:0.008803:0.004045:0.005214:0.003723
and memantine in Alzheimer’s disease and other demen-:@0.099709:0.847480:0.480964:0.847480:0.480964:0.833451:0.099709:0.833451:0.009179:0.008198:0.009206:0.004744:0.012606:0.008735:0.012606:0.009179:0.008198:0.004556:0.002688:0.008198:0.008735:0.004731:0.002688:0.008198:0.004744:0.009945:0.002688:0.005712:0.008198:0.008735:0.002688:0.012606:0.008735:0.004045:0.004717:0.005214:0.004731:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735:0.004744:0.009179:0.008198:0.009206:0.004744:0.008803:0.004556:0.008198:0.008735:0.004045:0.004731:0.009206:0.008735:0.012606:0.008735:0.008198:0.004462
tias. :@0.099709:0.859672:0.128791:0.859672:0.128791:0.845643:0.099709:0.845643:0.004556:0.002688:0.009179:0.005214:0.003723:0.003723
Dement Geriatr Cogn Dis Extra:@0.128791:0.859672:0.327785:0.859672:0.327785:0.845643:0.128791:0.845643:0.009999:0.008735:0.012606:0.008735:0.008198:0.004556:0.003723:0.011719:0.008735:0.004045:0.002688:0.009179:0.004556:0.004045:0.003723:0.010926:0.008803:0.009045:0.008198:0.003723:0.009999:0.002688:0.005214:0.003723:0.007203:0.006451:0.004556:0.004045:0.009179
. 2012;2(1):546-72.:@0.327771:0.859672:0.442663:0.859672:0.442663:0.845643:0.327771:0.845643:0.003723:0.003723:0.007445:0.007445:0.007445:0.007445:0.003723:0.007445:0.004959:0.007445:0.004959:0.003723:0.007445:0.007445:0.007445:0.004462:0.007445:0.007445:0.003723
4.  Gareri p, De Fazio p, Manfredi VG, De sarro G. Use and safe-:@0.076191:0.871864:0.480924:0.871864:0.480924:0.857835:0.076191:0.857835:0.007445:0.003723:0.003723:0.008628:0.011719:0.009179:0.004045:0.008735:0.004045:0.002688:0.002849:0.007956:0.003723:0.002849:0.009999:0.008735:0.002863:0.006518:0.009179:0.005712:0.002688:0.008803:0.002849:0.007956:0.003723:0.002849:0.012351:0.009179:0.008198:0.004220:0.004045:0.008735:0.009206:0.002688:0.002849:0.009434:0.011719:0.003723:0.002863:0.009999:0.008735:0.002863:0.006693:0.009179:0.004045:0.004045:0.008803:0.002849:0.011719:0.003723:0.002849:0.008803:0.005214:0.008735:0.002849:0.009179:0.008198:0.009206:0.002849:0.005214:0.009179:0.004220:0.008735:0.004462
ty of antipsychotics in behavioral disorders in elderly people :@0.099696:0.884056:0.484660:0.884056:0.484660:0.870027:0.099696:0.870027:0.004556:0.007203:0.002970:0.008803:0.004220:0.002970:0.009179:0.008198:0.004556:0.002688:0.009165:0.005214:0.007203:0.008695:0.008198:0.008803:0.004556:0.002688:0.008695:0.005214:0.002970:0.002688:0.008198:0.002970:0.009165:0.008735:0.008198:0.009179:0.007445:0.002688:0.008803:0.004045:0.009179:0.002688:0.002970:0.009206:0.002688:0.005214:0.008803:0.004045:0.009206:0.008735:0.004045:0.005214:0.002970:0.002688:0.008198:0.002970:0.008735:0.002688:0.009206:0.008735:0.004045:0.002688:0.007203:0.002970:0.009165:0.008735:0.008803:0.009165:0.002688:0.008735:0.003723
with dementia. :@0.099696:0.896248:0.201376:0.896248:0.201376:0.882219:0.099696:0.882219:0.011168:0.002688:0.004556:0.008198:0.003723:0.009206:0.008735:0.012606:0.008735:0.008198:0.004556:0.002688:0.009179:0.003723:0.003723
J Clin Psychopharmacol:@0.201363:0.896248:0.358413:0.896248:0.358413:0.882219:0.201363:0.882219:0.006478:0.003723:0.010926:0.002688:0.002688:0.008198:0.003723:0.007956:0.005214:0.007203:0.008695:0.008198:0.008803:0.009165:0.008198:0.009179:0.004045:0.012606:0.009179:0.008695:0.008803:0.002688
. 2014;34(1):109-23.:@0.358413:0.896248:0.480749:0.896248:0.480749:0.882219:0.358413:0.882219:0.003723:0.003723:0.007445:0.007445:0.007445:0.007445:0.003723:0.007445:0.007445:0.004959:0.007445:0.004959:0.003723:0.007445:0.007445:0.007445:0.004462:0.007445:0.007445:0.003723
5.  Kales HC, Gitlin LN, Lyketsos CG, Detroit Expert panel on the :@0.076177:0.908440:0.484673:0.908440:0.484673:0.894411:0.076177:0.894411:0.007445:0.003723:0.003723:0.008628:0.007943:0.009179:0.002688:0.008735:0.005214:0.003346:0.009179:0.010926:0.003723:0.003346:0.011719:0.002688:0.004556:0.002688:0.002688:0.008198:0.003346:0.006209:0.009945:0.003723:0.003333:0.006209:0.007203:0.006746:0.008735:0.004556:0.005214:0.008803:0.005214:0.003346:0.010926:0.011719:0.003723:0.003346:0.009999:0.008735:0.004556:0.004045:0.008803:0.002688:0.004556:0.003333:0.007203:0.006451:0.009165:0.008735:0.004045:0.004556:0.003346:0.007956:0.009179:0.008198:0.008735:0.002688:0.003346:0.008803:0.008198:0.003333:0.004556:0.008198:0.008735:0.003723
Assessment and Management of Neuropsychiatric symp-:@0.099696:0.920632:0.480937:0.920632:0.480937:0.906603:0.099696:0.906603:0.009945:0.005214:0.005214:0.008735:0.005214:0.005214:0.012606:0.008735:0.008198:0.004556:0.005416:0.009179:0.008198:0.009206:0.005416:0.012351:0.009179:0.008198:0.009179:0.009045:0.008735:0.012606:0.008735:0.008198:0.004556:0.005403:0.008803:0.004220:0.005416:0.009945:0.008735:0.008171:0.004045:0.008803:0.009165:0.005214:0.007203:0.008695:0.008198:0.002688:0.009179:0.004556:0.004045:0.002688:0.008695:0.005416:0.006693:0.007203:0.012606:0.009165:0.004462
toms  of  Dementia in Clinical  settings:  recommendations :@0.099696:0.932824:0.484660:0.932824:0.484660:0.918795:0.099696:0.918795:0.004556:0.008803:0.012606:0.005214:0.003723:0.002943:0.008803:0.004220:0.003723:0.002943:0.009999:0.008735:0.012606:0.008735:0.008198:0.004556:0.002688:0.009179:0.006679:0.002688:0.008198:0.006679:0.010926:0.002688:0.002688:0.008198:0.002688:0.008695:0.009179:0.002688:0.003723:0.002957:0.006693:0.008735:0.004556:0.004556:0.002688:0.008198:0.009045:0.005214:0.003723:0.003723:0.002943:0.004045:0.008735:0.008695:0.008803:0.012606:0.012606:0.008735:0.008198:0.009206:0.009179:0.004556:0.002688:0.008803:0.008198:0.005214:0.003723
from a multidisciplinary  expert panel. :@0.099696:0.945016:0.355389:0.945016:0.355389:0.930987:0.099696:0.930987:0.004220:0.004045:0.008803:0.012606:0.006841:0.009179:0.006841:0.012606:0.008171:0.002688:0.004556:0.002688:0.009206:0.002688:0.005214:0.008695:0.002688:0.009165:0.002688:0.002688:0.008198:0.009179:0.004045:0.007203:0.003723:0.003131:0.008735:0.006451:0.009165:0.008735:0.004045:0.004556:0.006841:0.009165:0.009179:0.008198:0.008735:0.002688:0.003723:0.003723
J Am Geriatr Soc:@0.358507:0.945016:0.477215:0.945016:0.477215:0.930987:0.358507:0.930987:0.006478:0.006841:0.009945:0.012606:0.006841:0.011719:0.008735:0.004045:0.002688:0.009179:0.004556:0.004045:0.006841:0.006693:0.008803:0.008695
. :@0.477215:0.945016:0.484660:0.945016:0.484660:0.930987:0.477215:0.930987:0.003723:0.003723
2014;62(4):762-9.:@0.542556:0.083623:0.650002:0.083623:0.650002:0.069594:0.542556:0.069594:0.007445:0.007445:0.007445:0.007445:0.003723:0.007445:0.007445:0.004959:0.007445:0.004959:0.003723:0.007445:0.007445:0.007445:0.004462:0.007445:0.003723
6.  Martin-Carrasco M, Ballesteros-Rodriguez J, Dominguez-:@0.519037:0.095825:0.923811:0.095825:0.923811:0.081796:0.519037:0.081796:0.007445:0.003723:0.003723:0.008628:0.012351:0.009179:0.004045:0.004556:0.002688:0.008198:0.004462:0.010926:0.009179:0.004045:0.004045:0.009179:0.005214:0.008695:0.008803:0.008601:0.012351:0.003723:0.008601:0.007714:0.009179:0.002688:0.002688:0.008735:0.005214:0.004556:0.008735:0.004045:0.008803:0.005214:0.004462:0.008158:0.008803:0.009206:0.004045:0.002688:0.009045:0.008171:0.008735:0.005712:0.008601:0.006478:0.003723:0.008601:0.009999:0.008803:0.012606:0.002688:0.008198:0.009045:0.008171:0.008735:0.005712:0.004462
panchon AI, Munoz-Hermoso p, Gonzalez-Fraile E. Interven-:@0.542556:0.108027:0.923797:0.108027:0.923797:0.093998:0.542556:0.093998:0.007956:0.009179:0.008198:0.008695:0.008198:0.008803:0.008198:0.003521:0.009945:0.003037:0.003723:0.003534:0.012351:0.008171:0.008198:0.008803:0.005712:0.004462:0.009179:0.008735:0.004045:0.012606:0.008803:0.005214:0.008803:0.003521:0.007956:0.003723:0.003534:0.011719:0.008803:0.008198:0.005712:0.009179:0.002688:0.008735:0.005712:0.004462:0.006518:0.004045:0.009179:0.002688:0.002688:0.008735:0.003521:0.007203:0.003723:0.003534:0.003037:0.008198:0.004556:0.008735:0.004045:0.007445:0.008735:0.008184:0.004462
tions for caregivers of patients with dementia. :@0.542556:0.120229:0.856306:0.120229:0.856306:0.106200:0.542556:0.106200:0.004556:0.002688:0.008803:0.008198:0.005214:0.006021:0.004220:0.008803:0.004045:0.006021:0.008695:0.009179:0.004045:0.008735:0.009045:0.002688:0.007445:0.008735:0.004045:0.005214:0.006021:0.008803:0.004220:0.006021:0.009165:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.005214:0.006021:0.011168:0.002688:0.004556:0.008198:0.006021:0.009206:0.008735:0.012606:0.008735:0.008198:0.004556:0.002688:0.009179:0.003723:0.003723
Actas Esp :@0.858604:0.120229:0.927520:0.120229:0.927520:0.106200:0.858604:0.106200:0.009945:0.008695:0.004556:0.009179:0.005214:0.006021:0.007203:0.005214:0.009165:0.003723
Psiquiatr:@0.542556:0.132432:0.596218:0.132432:0.596218:0.118403:0.542556:0.118403:0.007956:0.005214:0.002688:0.009165:0.008171:0.002688:0.009179:0.004556:0.004045
. 2014;42(6):300-14.:@0.596218:0.132432:0.718555:0.132432:0.718555:0.118403:0.596218:0.118403:0.003723:0.003723:0.007445:0.007445:0.007445:0.007445:0.003723:0.007445:0.007445:0.004959:0.007445:0.004959:0.003723:0.007445:0.007445:0.007445:0.004462:0.007445:0.007445:0.003723
7.  Matsunaga s, Kishi T, Iwata N. Combination therapy with :@0.519037:0.144634:0.927520:0.144634:0.927520:0.130605:0.519037:0.130605:0.007445:0.003723:0.003723:0.008628:0.012351:0.009179:0.004556:0.005214:0.008171:0.008198:0.009179:0.009045:0.009179:0.005658:0.006693:0.003723:0.005658:0.007943:0.002688:0.005214:0.008198:0.002688:0.005671:0.005725:0.003723:0.005658:0.003037:0.011168:0.009179:0.004556:0.009179:0.005671:0.009945:0.003723:0.005658:0.010926:0.008803:0.012606:0.009165:0.002688:0.008198:0.009179:0.004556:0.002688:0.008803:0.008198:0.005658:0.004556:0.008198:0.008735:0.004045:0.009179:0.009165:0.007203:0.005658:0.011168:0.002688:0.004556:0.008198:0.003723
cholinesterase inhibitors and memantine  for  Alzheimer’s :@0.542556:0.156836:0.927520:0.156836:0.927520:0.142807:0.542556:0.142807:0.008695:0.008198:0.008803:0.002688:0.002688:0.008198:0.008735:0.005214:0.004556:0.008735:0.004045:0.009179:0.005214:0.008735:0.007781:0.002688:0.008198:0.008198:0.002688:0.009165:0.002688:0.004556:0.008803:0.004045:0.005214:0.007781:0.009179:0.008198:0.009206:0.007781:0.012606:0.008735:0.012606:0.009179:0.008198:0.004556:0.002688:0.008198:0.008735:0.003723:0.004045:0.004220:0.008803:0.004045:0.003723:0.004045:0.009945:0.002688:0.005712:0.008198:0.008735:0.002688:0.012606:0.008735:0.004045:0.004717:0.005214:0.003723
disease: A systematic review and meta-analysis. :@0.542556:0.169038:0.861144:0.169038:0.861144:0.155009:0.542556:0.155009:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735:0.003723:0.004274:0.009945:0.004260:0.005214:0.007203:0.005214:0.004556:0.008735:0.012606:0.009179:0.004556:0.002688:0.008695:0.004274:0.004045:0.008735:0.007445:0.002688:0.008735:0.011168:0.004274:0.009179:0.008198:0.009206:0.004274:0.012606:0.008735:0.004556:0.009179:0.004462:0.009179:0.008198:0.009179:0.002688:0.007203:0.005214:0.002688:0.005214:0.003723:0.003723
Int J Neu-:@0.861695:0.169038:0.923797:0.169038:0.923797:0.155009:0.861695:0.155009:0.003037:0.008198:0.004556:0.004260:0.006478:0.004260:0.009945:0.008735:0.008171:0.004462
ropsychopharmacol:@0.542556:0.181241:0.675240:0.181241:0.675240:0.167212:0.542556:0.167212:0.004045:0.008803:0.009165:0.005214:0.007203:0.008695:0.008198:0.008803:0.009165:0.008198:0.009179:0.004045:0.012606:0.009179:0.008695:0.008803:0.002688
. 2014;18(5).:@0.675240:0.181241:0.752166:0.181241:0.752166:0.167212:0.675240:0.167212:0.003723:0.003723:0.007445:0.007445:0.007445:0.007445:0.003723:0.007445:0.007445:0.004959:0.007445:0.004959:0.003723
8.  sachdev  ps, Blacker D, Blazer DG, Ganguli M, Jeste DV, :@0.519037:0.193443:0.927507:0.193443:0.927507:0.179414:0.519037:0.179414:0.007445:0.003723:0.003723:0.008628:0.006693:0.009179:0.008695:0.008198:0.009206:0.008735:0.007445:0.003723:0.002392:0.007956:0.006693:0.003723:0.006115:0.007714:0.002688:0.009179:0.008695:0.006746:0.008735:0.004045:0.006115:0.009999:0.003723:0.006115:0.007714:0.002688:0.009179:0.005712:0.008735:0.004045:0.006115:0.009999:0.011719:0.003723:0.006115:0.011719:0.009179:0.008198:0.009045:0.008171:0.002688:0.002688:0.006115:0.012351:0.003723:0.006115:0.006478:0.008735:0.005214:0.004556:0.008735:0.006115:0.009999:0.009434:0.003723:0.003723
paulsen Js, :@0.542556:0.205645:0.618420:0.205645:0.618420:0.191616:0.542556:0.191616:0.007956:0.009179:0.008171:0.002688:0.005214:0.008735:0.008198:0.005107:0.006478:0.006693:0.003723:0.003723
et al:@0.619804:0.205645:0.650069:0.205645:0.650069:0.191616:0.619804:0.191616:0.008735:0.004556:0.005107:0.009179:0.002688
. Classifying neurocognitive disorders: The :@0.650069:0.205645:0.927547:0.205645:0.927547:0.191616:0.650069:0.191616:0.003723:0.005107:0.010926:0.002688:0.009179:0.005214:0.005214:0.002688:0.004220:0.007203:0.002688:0.008198:0.009045:0.005120:0.008198:0.008735:0.008171:0.004045:0.008803:0.008695:0.008803:0.009045:0.008198:0.002688:0.004556:0.002688:0.007445:0.008735:0.005093:0.009206:0.002688:0.005214:0.008803:0.004045:0.009206:0.008735:0.004045:0.005214:0.003723:0.005107:0.005725:0.008198:0.008735:0.003723
DsM-5 approach. :@0.542556:0.217847:0.661102:0.217847:0.661102:0.203818:0.542556:0.203818:0.009999:0.006693:0.012351:0.004462:0.007445:0.003723:0.009179:0.009165:0.009165:0.004045:0.008803:0.009179:0.008695:0.008198:0.003723:0.003723
Nat Rev Neurol:@0.661102:0.217847:0.758953:0.217847:0.758953:0.203818:0.661102:0.203818:0.009945:0.009179:0.004556:0.003723:0.008158:0.008735:0.007445:0.003723:0.009945:0.008735:0.008171:0.004045:0.008803:0.002688
. 2014;10(11):634-42.:@0.758939:0.217847:0.888721:0.217847:0.888721:0.203818:0.758939:0.203818:0.003723:0.003723:0.007445:0.007445:0.007445:0.007445:0.003723:0.007445:0.007445:0.004959:0.007445:0.007445:0.004959:0.003723:0.007445:0.007445:0.007445:0.004462:0.007445:0.007445:0.003723
9.  Tan CC, Yu JT, Wang HF, Tan Ms, Meng XF, Wang C, :@0.519037:0.230050:0.889944:0.230050:0.889944:0.216021:0.519037:0.216021:0.007445:0.003723:0.003723:0.008628:0.005725:0.009179:0.008198:0.004327:0.010926:0.010926:0.003723:0.004327:0.007956:0.008171:0.004327:0.006478:0.005725:0.003723:0.004327:0.012902:0.009179:0.008198:0.009045:0.004327:0.009179:0.006518:0.003723:0.004327:0.005725:0.009179:0.008198:0.004327:0.012351:0.006693:0.003723:0.004327:0.012351:0.008735:0.008198:0.009045:0.004327:0.008184:0.006518:0.003723:0.004327:0.012902:0.009179:0.008198:0.009045:0.004327:0.010926:0.003723:0.003723
et al:@0.890589:0.230050:0.920075:0.230050:0.920075:0.216021:0.890589:0.216021:0.008735:0.004556:0.004327:0.009179:0.002688
. :@0.920075:0.230050:0.927520:0.230050:0.927520:0.216021:0.920075:0.216021:0.003723:0.003723
Efficacy  and  safety  of  donepezil,  galantamine,  rivastig:@0.542556:0.242252:0.919322:0.242252:0.919322:0.228223:0.542556:0.228223:0.007203:0.004220:0.003272:0.003272:0.008695:0.009179:0.008695:0.007203:0.003723:0.003924:0.009179:0.008198:0.009206:0.003723:0.003924:0.005214:0.009179:0.004220:0.008735:0.004556:0.007203:0.003723:0.003911:0.008803:0.004220:0.003723:0.003911:0.009206:0.008803:0.008198:0.008735:0.009165:0.008735:0.005698:0.002688:0.002688:0.003723:0.003723:0.003924:0.009045:0.009179:0.002688:0.009179:0.008198:0.004556:0.009179:0.012606:0.002688:0.008198:0.008735:0.003723:0.003723:0.003911:0.004045:0.002688:0.007445:0.009179:0.005214:0.004556:0.002688:0.009045
-:@0.919322:0.242252:0.923784:0.242252:0.923784:0.228223:0.919322:0.228223:0.004462
mine, and memantine for the treatment of Alzheimer’s dis-:@0.542556:0.254454:0.923797:0.254454:0.923797:0.240425:0.542556:0.240425:0.012606:0.002688:0.008198:0.008735:0.003723:0.003951:0.009179:0.008198:0.009206:0.003951:0.012606:0.008735:0.012606:0.009179:0.008198:0.004556:0.002688:0.008198:0.008735:0.003951:0.004220:0.008803:0.004045:0.003951:0.004556:0.008198:0.008735:0.003951:0.004556:0.004045:0.008735:0.009179:0.004556:0.012606:0.008735:0.008198:0.004556:0.003951:0.008803:0.004220:0.003951:0.009945:0.002688:0.005712:0.008198:0.008735:0.002688:0.012606:0.008735:0.004045:0.004717:0.005214:0.003951:0.009206:0.002688:0.005214:0.004462
ease: A systematic review and meta-analysis. :@0.542556:0.266656:0.843969:0.266656:0.843969:0.252627:0.542556:0.252627:0.008735:0.009179:0.005214:0.008735:0.003723:0.004260:0.009945:0.004247:0.005214:0.007203:0.005214:0.004556:0.008735:0.012606:0.009179:0.004556:0.002688:0.008695:0.004260:0.004045:0.008735:0.007445:0.002688:0.008735:0.011168:0.004260:0.009179:0.008198:0.009206:0.004260:0.012606:0.008735:0.004556:0.009179:0.004462:0.009179:0.008198:0.009179:0.002688:0.007203:0.005214:0.002688:0.005214:0.003723:0.003723
J Alzheimers :@0.844506:0.266656:0.927533:0.266656:0.927533:0.252627:0.844506:0.252627:0.006478:0.004260:0.009945:0.002688:0.005712:0.008198:0.008735:0.002688:0.012606:0.008735:0.004045:0.005214:0.003723
Dis. :@0.542556:0.278859:0.567902:0.278859:0.567902:0.264830:0.542556:0.264830:0.009999:0.002688:0.005214:0.003723:0.003723
2014;41(2):615-31.:@0.567902:0.278859:0.682793:0.278859:0.682793:0.264830:0.567902:0.264830:0.007445:0.007445:0.007445:0.007445:0.003723:0.007445:0.007445:0.004959:0.007445:0.004959:0.003723:0.007445:0.007445:0.007445:0.004462:0.007445:0.007445:0.003723
referenCes:@0.519047:0.309405:0.625485:0.309405:0.625485:0.289240:0.519047:0.289240:0.010718:0.009609:0.008870:0.009609:0.010718:0.009609:0.013674:0.014413:0.009609:0.009609
1.  prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri Cp. The glob-:@0.519047:0.318622:0.923812:0.318622:0.923812:0.306346:0.519047:0.306346:0.006515:0.003257:0.003257:0.010489:0.006961:0.003540:0.002352:0.007173:0.007608:0.007644:0.002775:0.010807:0.003257:0.002775:0.006750:0.003540:0.006303:0.007608:0.007644:0.002775:0.007138:0.003257:0.002775:0.008702:0.002352:0.008020:0.008032:0.007173:0.007644:0.004563:0.007644:0.002775:0.006303:0.003257:0.002775:0.011289:0.002352:0.011030:0.007702:0.002775:0.008702:0.003257:0.002775:0.007138:0.002352:0.008020:0.007644:0.002352:0.003540:0.007702:0.002775:0.011289:0.003257:0.002775:0.005703:0.007644:0.003540:0.003540:0.002352:0.002775:0.009560:0.006961:0.003257:0.002775:0.005009:0.007173:0.007644:0.002775:0.007914:0.002352:0.007702:0.008020:0.003904
al prevalence of dementia: A systematic review and meta-analysis. :@0.542566:0.329415:0.927046:0.329415:0.927046:0.317140:0.542566:0.317140:0.008032:0.002352:0.002928:0.008020:0.003540:0.007644:0.006515:0.008032:0.002352:0.007644:0.007173:0.007608:0.007644:0.002928:0.007702:0.003692:0.002916:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.002916:0.008702:0.002916:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.002928:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.002928:0.008032:0.007173:0.008055:0.002928:0.011030:0.007644:0.003986:0.008032:0.003904:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.002352:0.004563:0.003257:0.003257
Alzheimers Dement.:@0.542566:0.340209:0.655302:0.340209:0.655302:0.327934:0.542566:0.327934:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004563:0.003257:0.008749:0.007644:0.011030:0.007644:0.007173:0.003986:0.003257
 2013;9(1):63-75 e2.:@0.655290:0.340209:0.763463:0.340209:0.763463:0.327934:0.655290:0.327934:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257:0.007644:0.006515:0.003257
2.  Gandy s, DeKosky sT. Toward the treatment and prevention of Alz-:@0.519047:0.351003:0.923812:0.351003:0.923812:0.338727:0.519047:0.338727:0.006515:0.003257:0.003257:0.010489:0.010254:0.008032:0.007173:0.008055:0.006303:0.003610:0.005856:0.003257:0.003610:0.008749:0.007644:0.006950:0.007702:0.004563:0.005903:0.006303:0.003610:0.005856:0.005009:0.003257:0.003610:0.005009:0.007702:0.009772:0.008032:0.003540:0.008055:0.003610:0.003986:0.007173:0.007644:0.003610:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003598:0.008032:0.007173:0.008055:0.003610:0.008020:0.003540:0.007644:0.006515:0.007644:0.007173:0.003986:0.002352:0.007702:0.007173:0.003610:0.007702:0.003692:0.003610:0.008702:0.002352:0.004998:0.003904
heimer’s disease: Rational strategies and recent progress. :@0.542566:0.361796:0.869837:0.361796:0.869837:0.349521:0.542566:0.349521:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.002869:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.002881:0.007138:0.008032:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.002881:0.004563:0.003986:0.003540:0.008032:0.003986:0.007644:0.007914:0.002352:0.007644:0.004563:0.002869:0.008032:0.007173:0.008055:0.002881:0.003540:0.007644:0.007608:0.007644:0.007173:0.003986:0.002869:0.008020:0.003540:0.007702:0.007914:0.003540:0.007644:0.004563:0.004563:0.003257:0.003257
Annu Rev :@0.869449:0.361796:0.927070:0.361796:0.927070:0.349521:0.869449:0.349521:0.008702:0.007173:0.007173:0.007150:0.002869:0.007138:0.007644:0.006515:0.003257
Med:@0.542566:0.372590:0.569071:0.372590:0.569071:0.360315:0.542566:0.360315:0.010807:0.007644:0.008055
. 2013;64:367-83.:@0.569071:0.372590:0.660922:0.372590:0.660922:0.360315:0.569071:0.360315:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
3.  Bensadon BA, Odenheimer GL. Current management decisions in :@0.519047:0.383384:0.927058:0.383384:0.927058:0.371109:0.519047:0.371109:0.006515:0.003257:0.003257:0.010489:0.006750:0.007644:0.007173:0.004563:0.008032:0.008055:0.007702:0.007173:0.004327:0.006750:0.008702:0.003257:0.004316:0.010219:0.008055:0.007644:0.007173:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004316:0.010254:0.005433:0.003257:0.004316:0.009560:0.007150:0.003540:0.003540:0.007644:0.007173:0.003986:0.004316:0.011030:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.004316:0.008055:0.007644:0.007608:0.002352:0.004563:0.002352:0.007702:0.007173:0.004563:0.004327:0.002352:0.007173:0.003257
mild cognitive impairment. :@0.542566:0.394178:0.697788:0.394178:0.697788:0.381902:0.542566:0.381902:0.011030:0.002352:0.002352:0.008055:0.003257:0.007608:0.007702:0.007914:0.007173:0.002352:0.003986:0.002352:0.006515:0.007644:0.003257:0.002352:0.011030:0.008020:0.008032:0.002352:0.003540:0.011030:0.007644:0.007173:0.003986:0.003257:0.003257
Clin Geriatr Med:@0.697788:0.394178:0.791591:0.394178:0.791591:0.381902:0.697788:0.381902:0.009560:0.002352:0.002352:0.007173:0.003257:0.010254:0.007644:0.003540:0.002352:0.008032:0.003986:0.003540:0.003257:0.010807:0.007644:0.008055
. 2013;29(4):847-71.:@0.791591:0.394178:0.898636:0.394178:0.898636:0.381902:0.791591:0.381902:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
4.  Rolinski M, Fox C, Maidment I, Mcshane R. Cholinesterase inhibitors :@0.519047:0.404971:0.927034:0.404971:0.927034:0.392696:0.519047:0.392696:0.006515:0.003257:0.003257:0.010489:0.007138:0.007702:0.002352:0.002352:0.007173:0.004563:0.005903:0.002352:0.003669:0.010807:0.003257:0.003657:0.005703:0.007702:0.005644:0.003657:0.009560:0.003257:0.003657:0.010807:0.008032:0.002352:0.008055:0.011030:0.007644:0.007173:0.003986:0.003657:0.002658:0.003257:0.003657:0.010807:0.007608:0.005856:0.007173:0.008032:0.007173:0.007644:0.003657:0.007138:0.003257:0.003657:0.009560:0.007173:0.007702:0.002352:0.002352:0.007173:0.007644:0.004563:0.003986:0.007644:0.003540:0.008032:0.004563:0.007644:0.003657:0.002352:0.007173:0.007173:0.002352:0.008020:0.002352:0.003986:0.007702:0.003540:0.004563:0.003257
for dementia with Lewy bodies, parkinson’s disease dementia and :@0.542566:0.415765:0.927070:0.415765:0.927070:0.403490:0.542566:0.403490:0.003692:0.007702:0.003540:0.004022:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.004033:0.009772:0.002352:0.003986:0.007173:0.004033:0.005433:0.007644:0.009772:0.006303:0.004033:0.008020:0.007702:0.008055:0.002352:0.007644:0.004563:0.003257:0.004033:0.006961:0.008032:0.003540:0.005903:0.002352:0.007173:0.004563:0.007702:0.007173:0.004127:0.004563:0.004033:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.004033:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.004033:0.008032:0.007173:0.008055:0.003257
cognitive impairment in parkinson’s disease. Cochrane Database :@0.542566:0.426559:0.927058:0.426559:0.927058:0.414283:0.542566:0.414283:0.007608:0.007702:0.007914:0.007173:0.002352:0.003986:0.002352:0.006515:0.007644:0.004939:0.002352:0.011030:0.008020:0.008032:0.002352:0.003540:0.011030:0.007644:0.007173:0.003986:0.004939:0.002352:0.007173:0.004939:0.006961:0.008032:0.003540:0.005903:0.002352:0.007173:0.004563:0.007702:0.007173:0.004127:0.004563:0.004939:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.004939:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.004927:0.008749:0.008032:0.003986:0.008032:0.008020:0.008032:0.004563:0.007644:0.003257
syst Rev. 2012;3:CD006504.:@0.542566:0.437352:0.694084:0.437352:0.694084:0.425077:0.542566:0.425077:0.005856:0.006303:0.004563:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
5.  Van de Glind EM, van Enst WA, van Munster BC, Olde Rikkert MG, :@0.519047:0.448146:0.927070:0.448146:0.927070:0.435871:0.519047:0.435871:0.006515:0.003257:0.003257:0.010489:0.008255:0.008032:0.007173:0.004116:0.008055:0.007644:0.004104:0.010254:0.002352:0.002352:0.007173:0.008055:0.004116:0.006303:0.010807:0.003257:0.004116:0.006515:0.008032:0.007173:0.004116:0.006303:0.007173:0.004563:0.003986:0.004116:0.011289:0.008702:0.003257:0.004104:0.006515:0.008032:0.007173:0.004116:0.010807:0.007150:0.007173:0.004563:0.003986:0.007644:0.003540:0.004104:0.006750:0.009560:0.003257:0.004116:0.010219:0.002352:0.008055:0.007644:0.004116:0.007138:0.002352:0.005903:0.005903:0.007644:0.003540:0.003986:0.004104:0.010807:0.010254:0.003257:0.003257
scheltens p, scholten RJ, :@0.542566:0.458940:0.688862:0.458940:0.688862:0.446665:0.542566:0.446665:0.005856:0.007608:0.007173:0.007644:0.002352:0.003986:0.007644:0.007173:0.004563:0.004421:0.006961:0.003257:0.004421:0.005856:0.007608:0.007173:0.007702:0.002352:0.003986:0.007644:0.007173:0.004421:0.007138:0.005668:0.003257:0.003257
et al:@0.690027:0.458940:0.716461:0.458940:0.716461:0.446665:0.690027:0.446665:0.007644:0.003986:0.004421:0.008032:0.002352
. pharmacological treatment of de-:@0.716461:0.458940:0.923789:0.458940:0.923789:0.446665:0.716461:0.446665:0.003257:0.004421:0.006961:0.007173:0.008032:0.003540:0.011018:0.008032:0.007608:0.007702:0.002352:0.007702:0.007914:0.002352:0.007608:0.008032:0.002352:0.004421:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.004410:0.007702:0.003692:0.004421:0.008055:0.007644:0.003904
mentia:  A  scoping  review  of  systematic  reviews. :@0.542566:0.469734:0.830491:0.469734:0.830491:0.457458:0.542566:0.457458:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.003257:0.002234:0.008702:0.003257:0.002234:0.004563:0.007608:0.007702:0.008020:0.002352:0.007173:0.007914:0.003257:0.002234:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257:0.002234:0.007702:0.003692:0.003257:0.002234:0.004563:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.003257:0.002234:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.004563:0.003257:0.003257
Dement  Geriatr :@0.832749:0.469734:0.927070:0.469734:0.927070:0.457458:0.832749:0.457458:0.008749:0.007644:0.011030:0.007644:0.007173:0.003986:0.003257:0.002234:0.010254:0.007644:0.003540:0.002352:0.008032:0.003986:0.003540:0.003257
Cogn Disord:@0.542566:0.480527:0.613133:0.480527:0.613133:0.468252:0.542566:0.468252:0.009560:0.007702:0.007914:0.007173:0.003257:0.008749:0.002352:0.004563:0.007702:0.003540:0.008055
. 2013;36(3-4):211-28.:@0.613121:0.480527:0.730584:0.480527:0.730584:0.468252:0.613121:0.468252:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.003904:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
6.  suehs BT,  shah  sN,  Davis CD, Alvir J,  Faison  WE,  patel NC, :@0.519047:0.491321:0.890816:0.491321:0.890816:0.479046:0.519047:0.479046:0.006515:0.003257:0.003257:0.010489:0.005856:0.007150:0.007644:0.007173:0.004563:0.005503:0.006750:0.005009:0.003257:0.003257:0.002246:0.005856:0.007173:0.008032:0.007173:0.003257:0.002246:0.005856:0.008702:0.003257:0.003257:0.002234:0.008749:0.008032:0.006515:0.002352:0.004563:0.005503:0.009560:0.008749:0.003257:0.005503:0.008702:0.002352:0.006515:0.002352:0.003540:0.005503:0.005668:0.003257:0.003257:0.002234:0.005703:0.008032:0.002352:0.004563:0.007702:0.007173:0.003257:0.002246:0.011289:0.006303:0.003257:0.003257:0.002246:0.006961:0.008032:0.003986:0.007644:0.002352:0.005503:0.008702:0.009560:0.003257:0.003257
et  al:@0.893038:0.491321:0.920543:0.491321:0.920543:0.479046:0.893038:0.479046:0.007644:0.003986:0.003257:0.002234:0.008032:0.002352
. :@0.920543:0.491321:0.927058:0.491321:0.927058:0.479046:0.920543:0.479046:0.003257:0.003257
Household members of persons with Alzheimer’s disease:  Health :@0.542566:0.502115:0.927070:0.502115:0.927070:0.489839:0.542566:0.489839:0.008032:0.007702:0.007150:0.004563:0.007644:0.007173:0.007702:0.002352:0.008055:0.006009:0.011030:0.007644:0.011030:0.008020:0.007644:0.003540:0.004563:0.006009:0.007702:0.003692:0.006009:0.008020:0.007644:0.003540:0.004563:0.007702:0.007173:0.004563:0.006009:0.009772:0.002352:0.003986:0.007173:0.006009:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.006009:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257:0.002763:0.008032:0.007644:0.008032:0.002352:0.003986:0.007173:0.003257
conditions, healthcare resource  use, and healthcare costs. :@0.542566:0.512908:0.891521:0.512908:0.891521:0.500633:0.542566:0.500633:0.007608:0.007702:0.007173:0.008055:0.002352:0.003986:0.002352:0.007702:0.007173:0.004563:0.003257:0.005080:0.007173:0.007644:0.008032:0.002352:0.003986:0.007173:0.007608:0.008032:0.003540:0.007644:0.005080:0.003540:0.007644:0.004563:0.007702:0.007150:0.003540:0.007608:0.007644:0.003257:0.001811:0.007150:0.004563:0.007644:0.003257:0.005080:0.008032:0.007173:0.008055:0.005080:0.007173:0.007644:0.008032:0.002352:0.003986:0.007173:0.007608:0.008032:0.003540:0.007644:0.005080:0.007608:0.007702:0.004563:0.003986:0.004563:0.003257:0.003257
J Am :@0.893344:0.512908:0.927081:0.512908:0.927081:0.500633:0.893344:0.500633:0.005668:0.005080:0.008702:0.011030:0.003257
Geriatr Soc:@0.542566:0.523702:0.606336:0.523702:0.606336:0.511427:0.542566:0.511427:0.010254:0.007644:0.003540:0.002352:0.008032:0.003986:0.003540:0.003257:0.005856:0.007702:0.007608
. 2014;62(3):435-41.:@0.606324:0.523702:0.713369:0.523702:0.713369:0.511427:0.606324:0.511427:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
7.  sachdev  ps,  Blacker D, Blazer DG, Ganguli M, Jeste DV,  paulsen :@0.519047:0.534496:0.927081:0.534496:0.927081:0.522220:0.519047:0.522220:0.006515:0.003257:0.003257:0.010489:0.005856:0.008032:0.007608:0.007173:0.008055:0.007644:0.006515:0.003257:0.001940:0.006961:0.005856:0.003257:0.003257:0.001929:0.006750:0.002352:0.008032:0.007608:0.005903:0.007644:0.003540:0.005198:0.008749:0.003257:0.005198:0.006750:0.002352:0.008032:0.004998:0.007644:0.003540:0.005198:0.008749:0.010254:0.003257:0.005198:0.010254:0.008032:0.007173:0.007914:0.007150:0.002352:0.002352:0.005198:0.010807:0.003257:0.005198:0.005668:0.007644:0.004563:0.003986:0.007644:0.005198:0.008749:0.008255:0.003257:0.003257:0.001940:0.006961:0.008032:0.007150:0.002352:0.004563:0.007644:0.007173:0.003257
Js, :@0.542566:0.545290:0.560604:0.545290:0.560604:0.533014:0.542566:0.533014:0.005668:0.005856:0.003257:0.003257
et al:@0.560546:0.545290:0.585757:0.545290:0.585757:0.533014:0.560546:0.533014:0.007644:0.003986:0.003199:0.008032:0.002352
. Classifying neurocognitive disorders: The DsM-5 approach. :@0.585757:0.545290:0.927058:0.545290:0.927058:0.533014:0.585757:0.533014:0.003257:0.003199:0.009560:0.002352:0.008032:0.004563:0.004563:0.002352:0.003692:0.006303:0.002352:0.007173:0.007914:0.003210:0.007173:0.007644:0.007150:0.003540:0.007702:0.007608:0.007702:0.007914:0.007173:0.002352:0.003986:0.002352:0.006515:0.007644:0.003187:0.008055:0.002352:0.004563:0.007702:0.003540:0.008055:0.007644:0.003540:0.004563:0.003257:0.003187:0.005009:0.007173:0.007644:0.003187:0.008749:0.005856:0.010807:0.003904:0.006515:0.003199:0.008032:0.008020:0.008020:0.003540:0.007702:0.008032:0.007608:0.007173:0.003257:0.003257
Nat Rev Neurol:@0.542566:0.556083:0.628185:0.556083:0.628185:0.543808:0.542566:0.543808:0.008702:0.008032:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.008702:0.007644:0.007150:0.003540:0.007702:0.002352
. 2014;10(11):634-42.:@0.628173:0.556083:0.741732:0.556083:0.741732:0.543808:0.628173:0.543808:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
8.  Harper L, Barkhof F, scheltens p, schott JM, Fox NC. An algorithmic :@0.519047:0.566877:0.927081:0.566877:0.927081:0.554602:0.519047:0.554602:0.006515:0.003257:0.003257:0.010489:0.008032:0.008032:0.003540:0.008020:0.007644:0.003540:0.003751:0.005433:0.003257:0.003751:0.006750:0.008032:0.003540:0.005903:0.007173:0.007702:0.003692:0.003751:0.005703:0.003257:0.003751:0.005856:0.007608:0.007173:0.007644:0.002352:0.003986:0.007644:0.007173:0.004563:0.003751:0.006961:0.003257:0.003751:0.005856:0.007608:0.007173:0.007702:0.003986:0.003986:0.003751:0.005668:0.010807:0.003257:0.003751:0.005703:0.007702:0.005644:0.003751:0.008702:0.009560:0.003257:0.003751:0.008702:0.007173:0.003751:0.008032:0.002352:0.007914:0.007702:0.003540:0.002352:0.003986:0.007173:0.011030:0.002352:0.007608:0.003257
approach to  structural  imaging in dementia. :@0.542566:0.577671:0.810147:0.577671:0.810147:0.565395:0.542566:0.565395:0.008032:0.008020:0.008020:0.003540:0.007702:0.008032:0.007608:0.007173:0.005433:0.003986:0.007702:0.003257:0.002164:0.004563:0.003986:0.003540:0.007150:0.007608:0.003986:0.007150:0.003540:0.008032:0.002352:0.003257:0.002164:0.002352:0.011030:0.008032:0.007914:0.002352:0.007173:0.007914:0.005433:0.002352:0.007173:0.005433:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.003257
J Neurol  Neurosurg :@0.812311:0.577671:0.927081:0.577671:0.927081:0.565395:0.812311:0.565395:0.005668:0.005433:0.008702:0.007644:0.007150:0.003540:0.007702:0.002352:0.003257:0.002164:0.008702:0.007644:0.007150:0.003540:0.007702:0.004563:0.007150:0.003540:0.007914:0.003257
Psychiatry:@0.542566:0.588464:0.599386:0.588464:0.599386:0.576189:0.542566:0.576189:0.006961:0.004563:0.006303:0.007608:0.007173:0.002352:0.008032:0.003986:0.003540:0.006303
. 2014;85(6):692-8.:@0.599386:0.588464:0.699916:0.588464:0.699916:0.576189:0.599386:0.576189:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.003257
9.  sansoni J, Anderson  KH, Varona LM, Varela  G. Caregivers of Alz-:@0.519047:0.599258:0.923812:0.599258:0.923812:0.586983:0.519047:0.586983:0.006515:0.003257:0.003257:0.010489:0.005856:0.008032:0.007173:0.004563:0.007702:0.007173:0.002352:0.005045:0.005668:0.003257:0.005045:0.008702:0.007173:0.008055:0.007644:0.003540:0.004563:0.007702:0.007173:0.003257:0.001776:0.006950:0.008032:0.003257:0.005045:0.008255:0.008032:0.003540:0.007702:0.007173:0.008032:0.005045:0.005433:0.010807:0.003257:0.005045:0.008255:0.008032:0.003540:0.007644:0.002352:0.008032:0.003257:0.001787:0.010254:0.003257:0.005045:0.009560:0.008032:0.003540:0.007644:0.007914:0.002352:0.006515:0.007644:0.003540:0.004563:0.005045:0.007702:0.003692:0.005045:0.008702:0.002352:0.004998:0.003904
heimer’s  patients  and  factors  influencing  institutionalization  of :@0.542566:0.610052:0.927070:0.610052:0.927070:0.597776:0.542566:0.597776:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.003257:0.005350:0.008020:0.008032:0.003986:0.002352:0.007644:0.007173:0.003986:0.004563:0.003257:0.005350:0.008032:0.007173:0.008055:0.003257:0.005350:0.003692:0.008032:0.007608:0.003986:0.007702:0.003540:0.004563:0.003257:0.005350:0.002352:0.007173:0.002852:0.002852:0.007150:0.007644:0.007173:0.007608:0.002352:0.007173:0.007914:0.003257:0.005350:0.002352:0.007173:0.004563:0.003986:0.002352:0.003986:0.007150:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.002352:0.004998:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.005350:0.007702:0.003692:0.003257
loved ones:  some considerations on existing literature. :@0.542566:0.620846:0.875917:0.620846:0.875917:0.608570:0.542566:0.608570:0.002352:0.007702:0.006515:0.007644:0.008055:0.007138:0.007702:0.007173:0.007644:0.004563:0.003257:0.003257:0.003881:0.005856:0.007702:0.011030:0.007644:0.007138:0.007608:0.007702:0.007173:0.004563:0.002352:0.008055:0.007644:0.003540:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.007138:0.007702:0.007173:0.007138:0.007644:0.005644:0.002352:0.004563:0.003986:0.002352:0.007173:0.007914:0.007138:0.002352:0.002352:0.003986:0.007644:0.003540:0.008032:0.003986:0.007150:0.003540:0.007644:0.003257:0.003257
Ann Ig:@0.879797:0.620846:0.920555:0.620846:0.920555:0.608570:0.879797:0.608570:0.008702:0.007173:0.007173:0.007138:0.002658:0.007914
. :@0.920555:0.620846:0.927070:0.620846:0.927070:0.608570:0.920555:0.608570:0.003257:0.003257
2013;25(3):235-46.:@0.542566:0.631639:0.643095:0.631639:0.643095:0.619364:0.542566:0.619364:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
10.  Madhusoodanan s, Ting MB. pharmacological management of be-:@0.519047:0.642433:0.923801:0.642433:0.923801:0.630158:0.519047:0.630158:0.006279:0.006279:0.003022:0.003257:0.004680:0.010572:0.007796:0.007820:0.006938:0.006914:0.004327:0.007467:0.007467:0.007820:0.007796:0.006938:0.007796:0.006938:0.004598:0.005621:0.003022:0.004598:0.004774:0.002117:0.006938:0.007679:0.004610:0.010572:0.006515:0.003022:0.004598:0.006726:0.006938:0.007796:0.003304:0.010795:0.007796:0.007373:0.007467:0.002117:0.007467:0.007679:0.002117:0.007373:0.007796:0.002117:0.004598:0.010795:0.007796:0.006938:0.007796:0.007679:0.007408:0.010795:0.007408:0.006938:0.003751:0.004598:0.007467:0.003457:0.004598:0.007785:0.007408:0.003904
havioral  symptoms  associated  with  dementia. :@0.542566:0.653227:0.811723:0.653227:0.811723:0.640951:0.542566:0.640951:0.006938:0.007796:0.006279:0.002117:0.007467:0.003304:0.007796:0.002117:0.003257:0.003540:0.004327:0.006068:0.010795:0.007785:0.003751:0.007467:0.010795:0.004327:0.003257:0.003540:0.007796:0.004327:0.004327:0.007467:0.007373:0.002117:0.007796:0.003751:0.007408:0.007820:0.003257:0.003540:0.009537:0.002117:0.003751:0.006938:0.003257:0.003540:0.007820:0.007408:0.010795:0.007408:0.006938:0.003751:0.002117:0.007796:0.003022:0.003257
World  J  Psychiatry:@0.815286:0.653227:0.920778:0.653227:0.920778:0.640951:0.815286:0.640951:0.011054:0.007467:0.003304:0.002117:0.007820:0.003257:0.003540:0.005433:0.003257:0.003540:0.006726:0.004327:0.006068:0.007373:0.006938:0.002117:0.007796:0.003751:0.003304:0.006303
. :@0.920543:0.653227:0.927058:0.653227:0.927058:0.640951:0.920543:0.640951:0.003257:0.003257
2014;4(4):72-9.:@0.542566:0.664020:0.620259:0.664020:0.620259:0.651745:0.542566:0.651745:0.006279:0.006279:0.006279:0.006279:0.003022:0.006279:0.004104:0.006279:0.004104:0.003022:0.006279:0.006279:0.003669:0.006279:0.003257
11.  Moniz Cook ED, swift K, James I, Malouf R, De Vugt M, Verhey F. :@0.519047:0.674814:0.927058:0.674814:0.927058:0.662539:0.519047:0.662539:0.006515:0.006515:0.003257:0.003257:0.003975:0.010807:0.007702:0.007173:0.002352:0.004998:0.004833:0.009560:0.007702:0.007702:0.005903:0.004833:0.006303:0.008749:0.003257:0.004845:0.005856:0.009772:0.002352:0.003692:0.003986:0.004845:0.006950:0.003257:0.004833:0.005668:0.008032:0.011030:0.007644:0.004563:0.004845:0.002658:0.003257:0.004845:0.010807:0.008032:0.002352:0.007702:0.007150:0.003692:0.004845:0.007138:0.003257:0.004833:0.008749:0.007644:0.004845:0.008255:0.007150:0.007914:0.003986:0.004833:0.010807:0.003257:0.004833:0.008255:0.007644:0.003540:0.007173:0.007644:0.006303:0.004833:0.005703:0.003257:0.003257
Functional analysis-based  interventions for challenging behaviour :@0.542566:0.685608:0.927081:0.685608:0.927081:0.673332:0.542566:0.673332:0.005703:0.007150:0.007173:0.007608:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.005174:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.002352:0.004563:0.003904:0.008020:0.008032:0.004563:0.007644:0.008055:0.003257:0.001940:0.002352:0.007173:0.003986:0.007644:0.003540:0.006515:0.007644:0.007173:0.003986:0.002352:0.007702:0.007173:0.004563:0.005174:0.003692:0.007702:0.003540:0.005174:0.007608:0.007173:0.008032:0.002352:0.002352:0.007644:0.007173:0.007914:0.002352:0.007173:0.007914:0.005174:0.008020:0.007644:0.007173:0.008032:0.006515:0.002352:0.007702:0.007150:0.003540:0.003257
in dementia. Cochrane Database syst Rev. 2012;2:CD006929.:@0.542566:0.696402:0.891298:0.696402:0.891298:0.684126:0.542566:0.684126:0.002352:0.007173:0.003257:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.003257:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.003257:0.008749:0.008032:0.003986:0.008032:0.008020:0.008032:0.004563:0.007644:0.003257:0.005856:0.006303:0.004563:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
12.  Gitlin LN, Kales HC, Lyketsos CG. Nonpharmacologic management :@0.519047:0.707195:0.927070:0.707195:0.927070:0.694920:0.519047:0.694920:0.006515:0.006515:0.003257:0.003257:0.003975:0.010254:0.002352:0.003986:0.002352:0.002352:0.007173:0.003363:0.005433:0.008702:0.003257:0.003363:0.006950:0.008032:0.002352:0.007644:0.004563:0.003363:0.008032:0.009560:0.003257:0.003363:0.005433:0.006303:0.005903:0.007644:0.003986:0.004563:0.007702:0.004563:0.003363:0.009560:0.010254:0.003257:0.003363:0.008702:0.007702:0.007173:0.008020:0.007173:0.008032:0.003540:0.011030:0.008032:0.007608:0.007702:0.002352:0.007702:0.007914:0.002352:0.007608:0.003351:0.011030:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.003257
of behavioral symptoms in dementia. :@0.542566:0.717989:0.757501:0.717989:0.757501:0.705714:0.542566:0.705714:0.007702:0.003692:0.003257:0.008020:0.007644:0.007173:0.008032:0.006515:0.002352:0.007702:0.003540:0.008032:0.002352:0.003257:0.004563:0.006303:0.011030:0.008020:0.003986:0.007702:0.011030:0.004563:0.003257:0.002352:0.007173:0.003257:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.003257
JAMA:@0.757489:0.717989:0.791368:0.717989:0.791368:0.705714:0.757489:0.705714:0.005668:0.008702:0.010807:0.008702
. 2012;308(19):2020-9.:@0.791356:0.717989:0.911430:0.717989:0.911430:0.705714:0.791356:0.705714:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.003257
13.  Gareri p, De Fazio p, Manfredi VG, De sarro G. Use and safety of an-:@0.519035:0.728783:0.923777:0.728783:0.923777:0.716507:0.519035:0.716507:0.006515:0.006515:0.003257:0.003257:0.003975:0.010254:0.008032:0.003540:0.007644:0.003540:0.002352:0.002905:0.006961:0.003257:0.002905:0.008749:0.007644:0.002916:0.005703:0.008032:0.004998:0.002352:0.007702:0.002905:0.006961:0.003257:0.002905:0.010807:0.008032:0.007173:0.003692:0.003540:0.007644:0.008055:0.002352:0.002905:0.008255:0.010254:0.003257:0.002916:0.008749:0.007644:0.002916:0.005856:0.008032:0.003540:0.003540:0.007702:0.002905:0.010254:0.003257:0.002905:0.007702:0.004563:0.007644:0.002905:0.008032:0.007173:0.008055:0.002916:0.004563:0.008032:0.003692:0.007644:0.003986:0.006303:0.002916:0.007702:0.003692:0.002905:0.008032:0.007173:0.003904
tipsychotics in behavioral disorders in elderly people with dementia. :@0.542542:0.739576:0.927023:0.739576:0.927023:0.727301:0.542542:0.727301:0.003986:0.002352:0.008020:0.004563:0.006303:0.007608:0.007173:0.007702:0.003986:0.002352:0.007608:0.004563:0.002857:0.002352:0.007173:0.002857:0.008020:0.007644:0.007173:0.008032:0.006515:0.002352:0.007702:0.003540:0.008032:0.002352:0.002857:0.008055:0.002352:0.004563:0.007702:0.003540:0.008055:0.007644:0.003540:0.004563:0.002857:0.002352:0.007173:0.002857:0.007644:0.002352:0.008055:0.007644:0.003540:0.002352:0.006303:0.002857:0.008020:0.007644:0.007702:0.008020:0.002352:0.007644:0.002857:0.009772:0.002352:0.003986:0.007173:0.002857:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.003257
J Clin Psychopharmacol.:@0.542542:0.750370:0.683218:0.750370:0.683218:0.738095:0.542542:0.738095:0.005668:0.003257:0.009560:0.002352:0.002352:0.007173:0.003257:0.006961:0.004563:0.006303:0.007608:0.007173:0.007702:0.008020:0.007173:0.008032:0.003540:0.011030:0.008032:0.007608:0.007702:0.002352:0.003257
 2014;34(1):109-23.:@0.683206:0.750370:0.786993:0.750370:0.786993:0.738095:0.683206:0.738095:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
14.  Lee  pE, Gill  ss, Freedman M, Bronskill  sE, Hillmer Mp, Rochon  pA. :@0.519024:0.761164:0.927046:0.761164:0.927046:0.748888:0.519024:0.748888:0.006515:0.006515:0.003257:0.003257:0.003975:0.005433:0.007644:0.007644:0.003257:0.002105:0.006961:0.006303:0.003257:0.005362:0.010254:0.002352:0.002352:0.002352:0.003257:0.002117:0.005856:0.005856:0.003257:0.005362:0.005703:0.003540:0.007644:0.007644:0.008055:0.011030:0.008032:0.007173:0.005362:0.010807:0.003257:0.005362:0.006750:0.003540:0.007702:0.007173:0.004563:0.005903:0.002352:0.002352:0.002352:0.003257:0.002105:0.005856:0.006303:0.003257:0.005362:0.008032:0.002352:0.002352:0.002352:0.011030:0.007644:0.003540:0.005362:0.010807:0.006961:0.003257:0.005362:0.007138:0.007702:0.007608:0.007173:0.007702:0.007173:0.003257:0.002105:0.006961:0.008702:0.003257:0.003257
Atypical antipsychotic drugs in the treatment of behavioural and :@0.542542:0.771958:0.927034:0.771958:0.927034:0.759682:0.542542:0.759682:0.008702:0.003986:0.006303:0.008020:0.002352:0.007608:0.008032:0.002352:0.004668:0.008032:0.007173:0.003986:0.002352:0.008020:0.004563:0.006303:0.007608:0.007173:0.007702:0.003986:0.002352:0.007608:0.004668:0.008055:0.003540:0.007150:0.007914:0.004563:0.004657:0.002352:0.007173:0.004668:0.003986:0.007173:0.007644:0.004657:0.003986:0.003540:0.007632:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.004657:0.007702:0.003692:0.004657:0.008020:0.007644:0.007173:0.008032:0.006515:0.002352:0.007702:0.007150:0.003540:0.008032:0.002352:0.004668:0.008032:0.007173:0.008055:0.003257
psychological symptoms of dementia:  systematic review. :@0.542542:0.782751:0.893015:0.782751:0.893015:0.770476:0.542542:0.770476:0.008020:0.004563:0.006303:0.007608:0.007173:0.007702:0.002352:0.007702:0.007914:0.002352:0.007608:0.008032:0.002352:0.007538:0.004563:0.006303:0.011030:0.008020:0.003986:0.007702:0.011030:0.004563:0.007538:0.007702:0.003692:0.007538:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.003257:0.004280:0.005856:0.006303:0.004563:0.003986:0.007644:0.011030:0.008032:0.003986:0.002352:0.007608:0.007538:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257:0.003257
BMJ:@0.897295:0.782751:0.920520:0.782751:0.920520:0.770476:0.897295:0.770476:0.006750:0.010807:0.005668
. :@0.920520:0.782751:0.927034:0.782751:0.927034:0.770476:0.920520:0.770476:0.003257:0.003257
2004;329(7457):75.:@0.542542:0.793545:0.645683:0.793545:0.645683:0.781270:0.542542:0.781270:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.006515:0.006515:0.006515:0.004339:0.003257:0.006515:0.006515:0.003257
15.  Ballard C, Waite J. The effectiveness of atypical antipsychotics for :@0.519024:0.804339:0.927058:0.804339:0.927058:0.792063:0.519024:0.792063:0.006515:0.006515:0.003257:0.003257:0.003975:0.006750:0.008032:0.002352:0.002352:0.008032:0.003540:0.008055:0.004245:0.009560:0.003257:0.004233:0.011289:0.008032:0.002352:0.003986:0.007644:0.004233:0.005668:0.003257:0.004233:0.005009:0.007173:0.007644:0.004233:0.007644:0.003692:0.003692:0.007644:0.007608:0.003986:0.002352:0.006515:0.007644:0.007173:0.007644:0.004563:0.004563:0.004233:0.007702:0.003692:0.004233:0.008032:0.003986:0.006303:0.008020:0.002352:0.007608:0.008032:0.002352:0.004245:0.008032:0.007173:0.003986:0.002352:0.008020:0.004563:0.006303:0.007608:0.007173:0.007702:0.003986:0.002352:0.007608:0.004563:0.004233:0.003692:0.007702:0.003540:0.003257
the treatment of aggression and psychosis in Alzheimer’s disease. :@0.542542:0.815132:0.927046:0.815132:0.927046:0.802857:0.542542:0.802857:0.003986:0.007173:0.007644:0.004598:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.004586:0.007702:0.003692:0.004598:0.008032:0.007914:0.007914:0.003540:0.007644:0.004563:0.004563:0.002352:0.007702:0.007173:0.004598:0.008032:0.007173:0.008055:0.004598:0.008020:0.004563:0.006303:0.007608:0.007173:0.007702:0.004563:0.002352:0.004563:0.004598:0.002352:0.007173:0.004598:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.004598:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.003257
Cochrane Database syst Rev. 2006(1):CD003476.:@0.542542:0.825926:0.821483:0.825926:0.821483:0.813651:0.542542:0.813651:0.009560:0.007702:0.007608:0.007173:0.003540:0.008032:0.007173:0.007644:0.003257:0.008749:0.008032:0.003986:0.008032:0.008020:0.008032:0.004563:0.007644:0.003257:0.005856:0.006303:0.004563:0.003986:0.003257:0.007138:0.007644:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.009560:0.008749:0.006515:0.006515:0.006515:0.006515:0.006515:0.006515:0.003257
16.  Azermai M, petrovic M, Elseviers MM, Bourgeois J, Van Bortel LM, van :@0.519024:0.836720:0.927011:0.836720:0.927011:0.824444:0.519024:0.824444:0.006397:0.006397:0.003140:0.003257:0.004327:0.008584:0.004880:0.007526:0.003422:0.010913:0.007914:0.002234:0.003257:0.010689:0.003140:0.003257:0.006844:0.007526:0.003869:0.003422:0.007585:0.006397:0.002234:0.007491:0.003257:0.010689:0.003140:0.003257:0.006185:0.002234:0.004445:0.007526:0.006397:0.002234:0.007526:0.003422:0.004445:0.003257:0.010689:0.010689:0.003140:0.003257:0.006632:0.007585:0.007032:0.003422:0.007796:0.007526:0.007585:0.002234:0.004445:0.003257:0.005550:0.003140:0.003257:0.008137:0.007914:0.007056:0.003257:0.006632:0.007585:0.003422:0.003869:0.007526:0.002234:0.003257:0.005315:0.010689:0.003140:0.003257:0.006397:0.007914:0.007173:0.003257
der stichele RH. systematic appraisal of dementia guidelines for the :@0.542542:0.847513:0.927034:0.847513:0.927034:0.835238:0.542542:0.835238:0.007937:0.007526:0.003422:0.003692:0.005739:0.003869:0.002234:0.007491:0.007056:0.007526:0.002234:0.007526:0.003692:0.007020:0.007914:0.003140:0.003692:0.005739:0.006185:0.004445:0.003869:0.007526:0.010913:0.007914:0.003869:0.002234:0.007491:0.003692:0.007914:0.007902:0.007902:0.003422:0.007914:0.002234:0.004445:0.007914:0.002234:0.003692:0.007585:0.003575:0.003692:0.007937:0.007526:0.010913:0.007526:0.007056:0.003869:0.002234:0.007914:0.003692:0.007796:0.007032:0.002234:0.007937:0.007526:0.002234:0.002234:0.007056:0.007526:0.004445:0.003692:0.003575:0.007585:0.003422:0.003692:0.003869:0.007056:0.007644:0.003257
management of behavioural and psychological symptoms. :@0.542542:0.858307:0.882126:0.858307:0.882126:0.846032:0.542542:0.846032:0.010913:0.007914:0.007056:0.007914:0.007796:0.007526:0.010913:0.007526:0.007056:0.003869:0.003798:0.007585:0.003575:0.003798:0.007902:0.007526:0.007056:0.007914:0.006397:0.002234:0.007585:0.007032:0.003422:0.007914:0.002234:0.003810:0.007914:0.007056:0.007937:0.003810:0.007902:0.004445:0.006185:0.007491:0.007056:0.007585:0.002234:0.007585:0.007796:0.002234:0.007491:0.007914:0.002234:0.003798:0.004445:0.006185:0.010913:0.007902:0.003869:0.007585:0.010913:0.004445:0.003140:0.003257
Ageing :@0.882678:0.858307:0.927046:0.858307:0.927046:0.846032:0.882678:0.846032:0.008584:0.007796:0.007526:0.002234:0.007056:0.007914:0.003257
Res Rev:@0.542542:0.869101:0.585734:0.869101:0.585734:0.856826:0.542542:0.856826:0.007020:0.007526:0.004445:0.003140:0.007020:0.007526:0.006515
. 2012;11(1):78-86.:@0.585616:0.869101:0.684029:0.869101:0.684029:0.856826:0.585616:0.856826:0.003140:0.003140:0.006397:0.006397:0.006397:0.006397:0.003140:0.006397:0.006397:0.004222:0.006397:0.004222:0.003140:0.006397:0.006397:0.003786:0.006397:0.006397:0.003257
17.  Rabins pV, Blacker D, Rovner BW, Rummans T, schneider Ls, Tariot :@0.519024:0.879895:0.927046:0.879895:0.927046:0.867619:0.519024:0.867619:0.006515:0.006515:0.003257:0.003257:0.003975:0.007138:0.008032:0.008020:0.002352:0.007173:0.004563:0.004410:0.006961:0.008255:0.003257:0.004410:0.006750:0.002352:0.008032:0.007608:0.005903:0.007644:0.003540:0.004398:0.008749:0.003257:0.004410:0.007138:0.007702:0.006515:0.007173:0.007644:0.003540:0.004398:0.006750:0.011289:0.003257:0.004410:0.007138:0.007150:0.011030:0.011030:0.008032:0.007173:0.004563:0.004410:0.005009:0.003257:0.004410:0.005856:0.007608:0.007173:0.007173:0.007644:0.002352:0.008055:0.007644:0.003540:0.004398:0.005433:0.005856:0.003257:0.004410:0.005009:0.008032:0.003540:0.002352:0.007702:0.003986:0.003257
pN, :@0.542542:0.890688:0.564720:0.890688:0.564720:0.878413:0.542542:0.878413:0.006961:0.008702:0.003257:0.003257
et al:@0.566378:0.890688:0.593319:0.890688:0.593319:0.878413:0.566378:0.878413:0.007644:0.003986:0.004927:0.008032:0.002352
. American psychiatric Association practice guideline for :@0.593319:0.890688:0.927046:0.890688:0.927046:0.878413:0.593319:0.878413:0.003257:0.004927:0.008702:0.011030:0.007644:0.003540:0.002352:0.007608:0.008032:0.007173:0.004927:0.006961:0.004563:0.006303:0.007608:0.007173:0.002352:0.008032:0.003986:0.003540:0.002352:0.007608:0.004927:0.008702:0.004563:0.004563:0.007702:0.007608:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.004927:0.008020:0.003540:0.008032:0.007608:0.003986:0.002352:0.007608:0.007644:0.004927:0.007914:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.004927:0.003692:0.007702:0.003540:0.003257
the treatment of patients with Alzheimer’s disease and other de-:@0.542542:0.901482:0.923777:0.901482:0.923777:0.889207:0.542542:0.889207:0.003986:0.007173:0.007644:0.005009:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.005009:0.007702:0.003692:0.005009:0.008020:0.008032:0.003986:0.002352:0.007644:0.007173:0.003986:0.004563:0.005009:0.009772:0.002352:0.003986:0.007173:0.005009:0.008702:0.002352:0.004998:0.007173:0.007644:0.002352:0.011030:0.007644:0.003540:0.004127:0.004563:0.005009:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.005021:0.008032:0.007173:0.008055:0.005009:0.007702:0.003986:0.007173:0.007644:0.003540:0.005009:0.008055:0.007644:0.003904
mentias. second edition. :@0.542542:0.912276:0.686910:0.912276:0.686910:0.900000:0.542542:0.900000:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.004563:0.003257:0.003257:0.005856:0.007644:0.007608:0.007702:0.007173:0.008055:0.003257:0.007644:0.008055:0.002352:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257
Am J Psychiatry:@0.686899:0.912276:0.775634:0.912276:0.775634:0.900000:0.686899:0.900000:0.008702:0.011030:0.003257:0.005668:0.003257:0.006961:0.004563:0.006303:0.007608:0.007173:0.002352:0.008032:0.003986:0.003540:0.006303
. 2007;164(12 suppl):5-56.:@0.775622:0.912276:0.917321:0.912276:0.917321:0.900000:0.775622:0.900000:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.006515:0.003257:0.005856:0.007150:0.008020:0.008020:0.002352:0.004339:0.003257:0.006515:0.003904:0.006515:0.006515:0.003257
18.  Henry G, Williamson D, Tampi RR. Efficacy and tolerability of anti:@0.519024:0.923069:0.919885:0.923069:0.919885:0.910794:0.519024:0.910794:0.006515:0.006515:0.003257:0.003257:0.003975:0.008032:0.007644:0.007173:0.003540:0.006303:0.004786:0.010254:0.003257:0.004786:0.011289:0.002352:0.002352:0.002352:0.002352:0.008043:0.011030:0.004563:0.007702:0.007173:0.004786:0.008749:0.003257:0.004786:0.005009:0.008032:0.011030:0.008020:0.002352:0.004786:0.007138:0.007138:0.003257:0.004786:0.006303:0.003692:0.002863:0.002863:0.007608:0.008032:0.007608:0.006303:0.004786:0.008032:0.007173:0.008055:0.004786:0.003986:0.007702:0.002352:0.007644:0.003540:0.008032:0.008020:0.002352:0.002352:0.002352:0.003986:0.006303:0.004786:0.007702:0.003692:0.004786:0.008032:0.007173:0.003986:0.002352
-:@0.919885:0.923069:0.923789:0.923069:0.923789:0.910794:0.919885:0.910794:0.003904
depressants in the treatment  of behavioral and psychological :@0.542542:0.933863:0.927046:0.933863:0.927046:0.921588:0.542542:0.921588:0.008055:0.007644:0.008020:0.003540:0.007644:0.004563:0.004563:0.008032:0.007173:0.003986:0.004563:0.007491:0.002352:0.007173:0.007491:0.003986:0.007173:0.007644:0.007491:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003257:0.004222:0.007702:0.003692:0.007491:0.008020:0.007644:0.007173:0.008032:0.006515:0.002352:0.007702:0.003540:0.008032:0.002352:0.007491:0.008032:0.007173:0.008055:0.007491:0.008020:0.004563:0.006303:0.007608:0.007173:0.007702:0.002352:0.007702:0.007914:0.002352:0.007608:0.008032:0.002352:0.003257
symptoms of dementia, a literature review of evidence. :@0.542542:0.944657:0.868744:0.944657:0.868744:0.932382:0.542542:0.932382:0.004563:0.006303:0.011030:0.008020:0.003986:0.007702:0.011030:0.004563:0.004316:0.007702:0.003692:0.004316:0.008055:0.007644:0.011030:0.007644:0.007173:0.003986:0.002352:0.008032:0.003257:0.004304:0.008032:0.004316:0.002352:0.002352:0.003986:0.007644:0.003540:0.008032:0.003986:0.007150:0.003540:0.007644:0.004304:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.004316:0.007702:0.003692:0.004304:0.007644:0.006515:0.002352:0.008055:0.007644:0.007173:0.007608:0.007644:0.003257:0.003257
Am J Alz-:@0.869802:0.944657:0.923789:0.944657:0.923789:0.932382:0.869802:0.932382:0.008702:0.011030:0.004316:0.005668:0.004316:0.008702:0.002352:0.004998:0.003904